1
Federal Grant Funding
Opportunities
Updated June 26, 2019
2
Contents Overview of Resources to Help Ohio Communities Combat the Opioid Epidemic .........................................................5
CURRENT FUNDING PROGRAMS THROUGH SAMHSA: .................................................................................................8
1. Mental and Substance Use Disorders Prevalence Study ............................................................................................ 8
2. Mental and Substance Use Disorder Practitioner Data .............................................................................................. 8
3. Tribal Opioid Response Grants.................................................................................................................................... 9
4. Expansion of Practitioner Education ......................................................................................................................... 10
5. Drug-Free Communities (DFC) Support Program - New ........................................................................................... 10
6. Drug-Free Communities (DFC) Support Program – Competing Continuation .......................................................... 11
PAST FUNDING PROGRAMS THROUGH SAMHSA: ...................................................................................................... 12
7. Rural Opioid Technical Assistance Grants ................................................................................................................. 12
8. Provider’s Clinical Support System – Universities Grants ......................................................................................... 12
9. National Evaluation of the Technology Transfer Center Program ............................................................................ 13
10. Transforming Lives Through Supported Employment .......................................................................................... 14
11. First Responders-Comprehensive Addiction and Recovery Act ............................................................................ 15
12. Minority Aids Initiative: Substance Use Disorder Treatment for Racial/Ethnic Minority Populations at High Risk
for HIV/AIDS ...................................................................................................................................................................... 15
13. Building Communities of Recovery ....................................................................................................................... 16
14. National Center of Excellence for Integrated Health Solutions ............................................................................ 17
15. Strategic Prevention Framework – Partnerships for Success ............................................................................... 18
16. Targeted Capacity Expansion: Special Projects ..................................................................................................... 18
17. Provider’s Clinical Support System – Medication Assisted Treatment Grant ....................................................... 19
18. Grants to Expand Substance Abuse Treatment Capacity in Family Drug Courts .................................................. 20
19. Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment Drug Courts and Adult Tribal
Healing to Wellness Courts ............................................................................................................................................... 21
20. Tribal Behavioral Health Grant Program ............................................................................................................... 22
21. Rural Opioids Technical Assistance Grants ........................................................................................................... 22
22. Center of Excellence for Protected Health Information Related to Mental and Substance Use Disorders ......... 23
23. State Opioid Response Grants .............................................................................................................................. 24
24. Prevention Technology Transfer Centers Cooperative Agreements .................................................................... 25
25. Opioid State Targeted Response Technical Assistance ......................................................................................... 26
26. Targeted Capacity Expansion: Medication Assisted Treatment – Prescription Drug and Opioid Addiction ........ 27
CURRENT FUNDING PROGRAMS THROUGH HRSA: .................................................................................................... 28
PAST FUNDING PROGRAMS THROUGH HRSA:.................................................................................................................. 28
27. Rural Communities Opioid Response Program – Assisted Treatment Expansion ................................................ 28
28. Rural Communities Opioid Response Program – Rural Centers of Excellence on Substance Use Disorders ....... 28
3
29. Fiscal Year (FY) 2019 Integrated Behavioral Health Services (IBHS) ..................................................................... 29
30. Opioid Workforce Expansion Program (OWEP) Paraprofessionals ...................................................................... 29
31. Opioid Workforce Expansion Program (OWEP) Professionals .............................................................................. 30
32. Graduate Psychology Education (GPE) Program ................................................................................................... 31
33. Rural Communities Opioid Response Program-Implementation ......................................................................... 31
34. Rural Communities Opioid Response Program-Evaluation .................................................................................. 33
35. Small Health Care Provider Quality Improvement Program ................................................................................. 33
36. Strengthening Systems of Care for People Living with HIV and Opioid Use Disorder .......................................... 34
37. Rural Residency Planning and Development Program ......................................................................................... 35
38. Rural Health Innovation and Transformation Technical Assistance ..................................................................... 35
39. U3D Maternal and Child Health Measurement Research Network (MRN) .......................................................... 36
40. Small Rural Hospital Improvement Program ........................................................................................................ 37
41. Rural Health Network Development Planning Program ....................................................................................... 37
42. Rural Communities Opioid Response Program – Technical Assistance ................................................................ 38
43. Rural Communities Opioid Response Program - Planning .................................................................................... 39
CURRENT FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH: .......................................................... 39
44. NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) ............................................... 39
45. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention ... 40
46. Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional) ............................................. 41
47. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R43/R44
- Clinical Trial Optional) ..................................................................................................................................................... 42
48. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to Stop the Opioid Crisis (R41/R42
- Clinical Trial Optional) ..................................................................................................................................................... 43
49. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R01
- Clinical Trial Optional) ..................................................................................................................................................... 44
50. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses: Epidemiology and Prevention (R21
- Clinical Trial Optional) ..................................................................................................................................................... 45
51. NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed) ...... 45
52. Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders
(R34 Clinical Trial Optional) ............................................................................................................................................... 46
53. Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse Prevention Trials (R34 Clinical Trial
Optional) ........................................................................................................................................................................... 47
54. Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01
Clinical Trial Optional) ....................................................................................................................................................... 48
55. Multi-Site Pilot & Feasibility Studies for System-Level Implementation of Substance Use Prevention and
Treatment Services (R34 Clinical Trial Optional) .............................................................................................................. 49
56. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the
U.S. (R21 Clinical Trial Optional) ....................................................................................................................................... 50
4
57. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the
U.S. (R01 Clinical Trial Optional) ....................................................................................................................................... 51
PAST FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH: ................................................................. 52
58. HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium (PL1 Clinical Trial Not Allowed)..... 52
59. HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis Patients: The Hemodialysis Opioid
Prescription Effort (HOPE) Consortium - Clinical Centers (U01 Clinical Trial Required) ................................................... 53
60. HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use Disorder and Overdose for Drug
Screening (UH2/UH3 Clinical Trial Not Allowed) .............................................................................................................. 54
61. HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose (UG3/UH3 Clinical Trial Not
Allowed) ............................................................................................................................................................................ 55
[email protected] ..................................................................................................................................................... 56
62. HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Clinical Research Centers (UG1 Clinical
Trial Optional) ................................................................................................................................................................... 56
63. HEAL Initiative: Justice Community Opioid Innovation Network Coordination and Translation Center .............. 57
CURRENT FUNDING PROGRAMS THROUGH DOJ’S OFFICE OF JUSTICE PROGRAMS (OJP): ........................................... 58
64. Justice and Mental Health Collaboration Program FY 2019 Competitive Grant Announcement (BJA) ............... 58
PAST FUNDING PROGRAMS THROUGH OJP:.............................................................................................................. 59
66. Improving Reentry for Adults with Co-occurring Substance Abuse and Mental Illness (BJA) .............................. 59
67. Second Chance Act Comprehensive Community-based Adult Reentry Program (BJA) ........................................ 60
68. Improving Justice and Mental Health Collaboration: Training and Technical Assistance to Grantees and the
Field (BJA) .......................................................................................................................................................................... 61
69. Comprehensive Opioid Abuse Site-based Program (BJA) ..................................................................................... 62
70. Juvenile Drug Treatment Court Program (OJJDP) ................................................................................................. 63
71. Family Drug Court Program (OJJDP) ..................................................................................................................... 64
72. Office Anti-Heroin Task Force (AHTF) Program Application Guide (COPS) ........................................................... 65
73. Tribal Justice CTAS Training and Technical Assistance Solicitation (BJA).............................................................. 66
74. Opioid Affected Youth Initiative (OJJDP) .............................................................................................................. 66
75. Drug Court Training and Technical Assistance Program (OJJDP) .......................................................................... 67
76. Research and Evaluation on Drugs and Crime (NIJ) .............................................................................................. 68
77. Residential Substance Abuse Treatment (RSAT) for State Prisoners Program ..................................................... 69
78. Mentoring Opportunities for Youth Initiative: Category 1-5: (OJJDP) .................................................................. 69
79. Innovative Prosecution Solutions for Combating Violent Crime (BJA) ................................................................. 71
80. Adult Drug Court Discretionary Grant Program (BJA) ........................................................................................... 72
81. Adult Drug Court and Veterans Treatment Court Planning, Training, Technical Assistance and Resource Center
Initiative (BJA) ................................................................................................................................................................... 73
82. U.S. Department of Justice Coordinated Tribal Assistance Solicitation ................................................................ 73
5
Overview of Resources to Help Ohio Communities Combat the Opioid Epidemic
The Comprehensive Addiction and Recovery Act:
On July 22, 2016, President Obama signed into law Senator Portman’s Comprehensive Addiction and Recovery Act
(CARA), which fundamentally transforms the way the federal government treats addiction. CARA was funded at $267
million for Fiscal Year 2017. The Trump Administration’s FY 2019 budget includes $17 billion in resources to combat
the opioid epidemic. In addition, the bipartisan congressional budget deal includes $6 billion in additional resources for
FYs 2018-2019.
CARA Policy Reforms Implemented by Federal Agencies:
• Nurse practitioners and physicians assistants are now able to provide life-saving medication-assisted treatment.
• States, hospitals and social services will now report, track and assist drug dependent newborns and their families.
• The Department of Veterans Affairs (VA) will follow opioid prescribing guidelines and put in place stronger
oversight and accountability for the quality of care that they are providing our veterans. The VA will increase
coordination and communication throughout the VA with medical facilities, providers, patients and their families
and will hold the VA system accountable for appropriate care and quality standards. The VA will strengthen patient
advocacy programs, expands access to integrative health and wellness, and enhance VA hiring practices to help
prevent bad doctors from treating veterans.
Sample of CARA Grant Awards:
• $400,000 to establish or enhance local drug courts.
• $150,000 to expand addiction recovery support services.
• $300,000 for drug overdose outreach projects to fund new approaches to connect an overdose survivor to treatment
services.
• $750,000 to pilot programs that use technology to expand treatment and recovery support services for individuals in
rural areas.
• $400,000 for diversion and alternative to incarceration projects in the criminal justice system.
• $100,000 to fund statewide planning, coordination, and implementation projects between the criminal justice system
and addiction and mental health services.
• $400,000 to enhance prescription drug monitoring programs.
• More grant options included in this document.
Outstanding Actions to Fully Implement CARA:
• Inter-Agency Task Force on Best Practices for Prescribers of Pain Medication - Report on pain management
research and opioid prescribing and develop a strategy for disseminating information about best practices for pain
management, opioid prescribing, and alternatives to opioids.
• National Public Awareness Campaign - National education and awareness campaign to address the dangers of
opioid abuse and the association between prescription opioid abuse and heroin use and the dangerous effects of
fentanyl.
• Expand Prescription Drug Take Back Programs - Coordinate with law enforcement, hospitals, and pharmacies to
expand or make available disposal sites for unwanted prescription medications.
• Information Materials and Resources to Prevent Addiction Related to Youth Sports Injuries - Information focused
on youth sports injuries and the risks associated with opioid use and misuse, treatment options for such injuries that
do not involve the use of opioids, and how parents and youth can seek treatment for addiction.
• FDA Action Plan on Approving New Opioids - FDA must seek recommendations from an advisory committee prior
to approving any new opioid and must specifically label any drug that is an opioid intended for use in pediatric
populations. FDA must develop and dispense guidance on educating prescribers on opioid abuse and the use of
abuse deterrent opioids.
• Opioid Research by the National Institute of Health - Intensify and coordinate clinical research with respect to
understanding pain, developing alternative therapies for chronic pain, and developing alternatives to opioids for
effective pain treatments.
6
The 21st Century Cures Act:
On December 13, 2016, President Obama signed legislation to provide $1 billion to combat the opioid crisis. Ohio
received $26 million in Fiscal Year 2017 to help address the opioid crisis by increasing access to treatment, reducing
unmet treatment needs, and reducing opioid-related overdose deaths. Cures Act Funding Opportunities can be found at
this link on the Ohio Department of Mental Health and Addiction Services’ website:
http://mha.ohio.gov/Default.aspx?tabid=889.
Grants through OhioMHAS of FY19:
Emergency Department CURES Grant RFA (July 12): OMHAS seeks to fund case management positions in up four
additional hospital emergency department settings to coordinate clinical care for persons with substance use disorders
including opioid use disorders (SUD/OUD).
Request for Proposals (RFP) Behavioral Health and Juvenile Justice (June 10): OMHAS seeks to build upon the
earlier generations of the mental health service activities for juvenile justice-involved youth and supports a solid
foundation of community collaboration. Improvements may include prevention, early identification, evidence based/
informed practices and treatment models; and, sharing resources and developing partnerships between communities’
caregivers and service systems, and their counterparts at the state level.
RFI Understanding the Status of Kindergarten-12 Grade Prevention Education in Ohio (June 5): OHMAS seeks to
understand the status of kindergarten through grade 12 prevention education across the state. Its findings will be used to
inform future state-level investments and opportunities aimed at helping communities build and leverage partnerships to
deploy prevention education practices.
SOR Provide or Expand Peer Supports Initiative for Persons in Recovery from OUD (May 10): OMHAS seeks to
increase the availability of peer supports for persons in recovery from OUD and their families, including persons on all
forms of medication assisted treatment for OUD.
SOR MOMS Trainer Grant RFA (April 26): OMHAS seeks to award funding to one entity to provide training on the
Maternal Opiate Medical Supports model of care for pregnant women with opioid use disorder.
MOMS Implementation Site Grant (April 26): OMHAS seeks to award funding to support maternal care homes that
provide timely access to appropriate addiction and mental health services during pregnancy that extends postpartum,
including intensive home-based or residential treatment.
SOR Housing for Persons in Recovery from OUD Initiative (April 12): OMHAS seeks to increase the availability of
housing for persons in recovery from OUD and their families, including recovery housing that accepts all forms of
medication assisted treatment for OUD. Applications will be accepted from any ADAMHS county board.
Youth Resiliency Program (February 28): OMHAS seeks to award funding to support youth resiliency programming
for at-risk youth. Under this program, organizations may apply for one-time, stop-gap funding to help develop and/or
build capacity for services and programming designed to ensure that at-risk youth enjoy healthy development, succeed in
school, and grow up to be productive, adult citizens.
RFA SOR GPRA (February 22): OMHAS seeks to partner with a college or university to manage the required
Government Performance and Results Act (GPRA) survey data collection and reporting for the Ohio SOR project. The
selected applicant will provide training and support to the SOR providers collecting required Government Performance
and Results Act (GPRA) data, monitor data collected for data integrity, and regularly report to OMHAS relating to the
data collection process.
SOR Medical School Curriculum Program (February 22): OMHAS seeks to award funding to develop and implement
a common curriculum across all Ohio Medical schools to train 11,000 graduate medical students per year on pain
management and opioid use disorder treatment.
7
SOR Quality Housing Criteria (January 26): OMHAS is offering one statewide grant to a Housing Advocacy
Organization to assist with administrative duties related to the Quality Housing Criteria.
SOR Local Projects Funding (January 25): OMHAS seeks to partner with local ADAMHS boards to implement
treatment and recovery programs that expand access to medication assisted treatment (MAT).
Ohio Institutional Expert MAT WAIVER Trainer Live and In-person Training (December 28, 2018): OMHAS
seeks to partner with ten (10) hospitals with active and accredited residency programs across Ohio to provide DEA DATA
2000 Waiver trainings for resident physicians and physicians in Ohio.
SOR Distribution of Drug Destruction Bags (December 14, 2018): OMHAS seeks to award funding to one entity to
purchase and distribute drug destruction bags to community networks such as senior centers, schools, police and fire
departments, and hospitals.
Opioid Sequential Intercept Mapping (SIM) Action Plan (December 3, 2018): OMHAS will provide funding to
support up to three county ADAMHS Boards that have participated in an Opioid Sequential Intercept Mapping (SIM)
Workshop offered by Northeast Ohio Medical University (NEOMED). As part of the SIM workshop, participants are
tasked with developing an action plan which identifies top priority areas to help improve system and service level
responses for criminal justice involved individuals with an opioid use disorder (OUD).
SOR Ohio SBIRT Trainer (November 30, 2018): OMHAS seeks to expand Screening, Brief Intervention and Referral
to Treatment (SBIRT) training by partnering with three non-profit, accredited, universities or colleges to provide SBIRT
training for healthcare organizations within their awarded catchment area. SBIRT is an evidence based practice used to
identify, reduce, and prevent opioid use disorder.
Guidelines for MAT Transition of Care (November 23, 2018): OMHAS seeks to award funding to one entity to
develop inpatient medical setting guidelines for providing services and transitioning care of patients with opioid use
disorders (OUD) and/or other substance use disorders (SUD).
Ohio Institutional Expert MAT Trainer Grant (October 26, 2018): OMHAS seeks to partner with ten hospitals with
active and accredited residency programs across Ohio to provide DEA DATA 2000 Waiver trainings for resident
physicians and physicians in Ohio. The awardee will have two of their waivered physicians engage with Providers
Clinical Support System (PCSS) to complete PCSS requirements to become a Course Instructor for MAT Waiver
Training. The hospital will then sponsor two (2) MAT Waiver Trainings at their facility for physicians and resident
physicians both at their hospital and/or from other areas in the grant year.
MOMS Trainer Grant (August 27, 2018): OMHAS seeks to award funding to one entity to provide training on the
Maternal Opiate Medical Supports model of care for pregnant women with opioid use disorder.
Senator Portman’s Grant Coordinator: Avery Pierson
[email protected] or [email protected]
614.469.6774
Fiscal Year 2019 Grant Announcements and Awards:
https://www.samhsa.gov/grants/grant-announcements-2019
Developing a Competitive SAMHSA Grant Application:
https://www.samhsa.gov/sites/default/files/sites/default/grant_application_manual_508_compliance.pdf
SAMHSA Applicant Webinar for FY 2018:
https://www.youtube.com/watch?v=BFluJUvrM-g&feature=youtu.be
8
Listing of Grant Drug-Treatment Related Postings through the U.S. Department of Health & Human Services Substance
Abuse and Mental Health Services Administration
CURRENT FUNDING PROGRAMS THROUGH SAMHSA:
1. Mental and Substance Use Disorders Prevalence Study
https://www.samhsa.gov/grants/grant-announcements/fg-19-003
FOA Number: FG-19-003 Application Due Date: Friday, August 16, 2019
Description: The purpose of this grant program is to ensure that gaps in surveillance of individuals with serious mental
illness are addressed through a pilot program which assists in estimating the actual number of individuals living with
mental and substance use disorders, including those of the greatest severity.
Eligibility:
Domestic public and private non-profit entities.
Anticipated Total Available Funding: $30 million Anticipated Number of Awards: One
Length of Project: 3 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $30,000,000 in total costs (direct and indirect) in any year of the proposed project.
Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and
objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Beverly Vayhinger - Office of Financial Resources
(240) 276-0564
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
2. Mental and Substance Use Disorder Practitioner Data https://www.samhsa.gov/grants/grant-announcements/fg-19-002
FOA Number: FG-19-002 Application Due Date: Monday, August 12, 2019
Description: The purpose of this program is to provide comprehensive data and analysis on individuals who comprise the
prevention and treatment fields to address mental and substance use disorders. The goal of the program is to provide valid
data on the existing practitioners and usable information to SAMHSA on which to make policy and planning decisions.
Eligibility:
Public or private non-profit domestic entities
Anticipated Total Available Funding: $1 million Anticipated Number of Awards: One
9
Anticipated Award Amount: $1 million Length of Project: 3 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $1,000,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
3. Tribal Opioid Response Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-012
FOA Number: TI-19-012 Application Due Date: Tuesday, August 6, 2019
Description: The purpose of this program is to address the opioid crisis in tribal communities by increasing access to
culturally appropriate and evidence-based treatment, including medication-assisted treatment (MAT) using one of the
three FDA-approved medications for the treatment of opioid use disorder (OUD). The intent is to reduce unmet treatment
need and opioid overdose-related deaths through the provision of prevention, treatment and/or recovery activities for
OUD.
Eligibility:
Federally recognized tribes and tribal organizations. Tribes and tribal organizations may elect to apply as part of a
consortia or in partnership with urban Indian organizations. Tribes and tribal organizations may only be included
in one grant application.
Anticipated Total Available Funding: $35,985,372 Anticipated Number of Awards: 163
Anticipated Award Amount: See Appendix K of FOA (varies by tribe) Length of Project: 2 years
Cost Sharing/Match Required?: No
Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and
objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Grants Management and Budget Issues
10
4. Expansion of Practitioner Education https://www.samhsa.gov/grants/grant-announcements/fg-19-001
FOA Number: FG-19-001 Application Due Date: Friday, August 2, 2019
Description: The purpose of this program is to expand the integration of substance use disorder (SUD) education into the
standard curriculum of relevant healthcare and health services education programs. Through the mainstreaming of this
education, the ultimate goal is to expand the number of practitioners to deliver high-quality, evidence-based SUD
treatment.
Eligibility:
Public or private non-profit professional organizations representing healthcare professionals in the fields of
medicine, physician assistants, nursing, social work, psychology, marriage and family therapy, health services
administration.
Anticipated Total Available Funding: $2.5 million Anticipated Number of Awards: 10
Anticipated Award Amount: $250,000 Length of Project: 2 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $250,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information:
Program Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
5. Drug-Free Communities (DFC) Support Program - New https://www.samhsa.gov/grants/grant-announcements/sp-19-005
FOA Number: SP-19-005 Application Due Date: Monday, July 8, 2019
Description: The purpose of this program is to establish and strengthen collaboration among communities, public and
private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community
coalitions working to prevent and reduce substance abuse among youth. In addition to this, another purpose is to reduce
substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a
community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.
Eligibility:
Community-based coalitions addressing youth substance use that have never received a DFC grant.
Must meet all statutory eligibility requirements which are summarized in Table 1 in the DFC Act.
11
Anticipated Total Available Funding: $18.75 million Anticipated Number of Awards: 150
Anticipated Award Amount: Up to $125,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: Yes
Proposed budgets cannot exceed $125,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
DFC FOA Helpline Team
Office of Drug-Free Communities
Grants Management and Budget Issues
Odessa Crocker - Office of Financial Resources Division of Grants Management
5600 Fishers Lane
Rockville, Maryland 20857
6. Drug-Free Communities (DFC) Support Program – Competing Continuation https://www.samhsa.gov/grants/grant-announcements/sp-19-006
FOA Number: SP-19-006 Application Due Date: Monday, July 8, 2019
Description: The purpose of this program is to establish and strengthen collaboration among communities, public and
private non-profit agencies, as well as federal, state, local, and tribal governments to support the efforts of community
coalitions working to prevent and reduce substance abuse among youth. In addition to this, another purpose is to reduce
substance abuse among youth and, over time, reduce substance abuse among adults by addressing the factors in a
community that increase the risk of substance abuse and promoting the factors that minimize the risk of substance abuse.
Eligibility:
Community-based coalitions addressing youth substance use that have previously received a DFC grant but
experienced a lapse in funding or have concluded the first five-year funding cycle and are applying for a second
five-year funding cycle.
Must meet all statutory eligibility requirements which are summarized in Table 1 in the DFC Act.
Anticipated Total Available Funding: $18.75 million Anticipated Number of Awards: 150
Anticipated Award Amount: Up to $125,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: Yes
Proposed budgets cannot exceed $125,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
DFC FOA Helpline Team
Office of Drug-Free Communities
12
Grants Management and Budget Issues
Odessa Crocker - Office of Financial Resources Division of Grants Management
5600 Fishers Lane
Rockville, Maryland 20857
PAST FUNDING PROGRAMS THROUGH SAMHSA:
7. Rural Opioid Technical Assistance Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-010
FOA Number: TI-19-010 Application Due Date: Friday, June 7, 2019
Description: The purpose of this program is to develop and disseminate training and technical assistance for rural
communities on addressing opioid issues affecting these communities. It is expected that grantees will facilitate the
identification of model programs, develop and update materials related to the prevention, treatment and recovery activities
for opioid use disorder (OUD), and ensure that high-quality training is provided.
Eligibility:
Existing USDA Cooperative Extensions grantees
ROTA grantees that received an award in FY 2018 under announcement TI-18-022 are not eligible to apply
Anticipated Total Available Funding: $6.6 million Anticipated Number of Awards: 11
Anticipated Award Amount: $550,000 Length of Project: 2 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $550,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Humberto Carvalho - Center for Substance Abuse Treatment, Division of Service Improvement
(240) 276-2974
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
8. Provider’s Clinical Support System – Universities Grants https://www.samhsa.gov/grants/grant-announcements/ti-19-011
FOA Number: TI-19-011 Application Due Date: Friday, June 7, 2019
13
Description: The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services
for persons with an opioid use disorder (OUD) seeking or receiving MAT through ensuring the education and training of
students in the medical, physician assistant and nurse practitioner fields. This program’s focus is to ensure students fulfill
the training requirements needed to obtain a DATA waiver to prescribe MAT in office-based settings. The desired
outcomes include: 1) an increase in the number of individuals completing the training requirements for the DATA waiver,
2) an increase the number of individuals with a DATA waiver, and 3) an ultimate increase in those prescribing.
Eligibility:
Eligible applicants are medical schools, physician assistant schools, and schools of nursing
PCSS-Universities grantees that received an award in FY 2018 under announcement TI-18-014 are not eligible to
apply for this program.
Anticipated Total Available Funding: $3 million Anticipated Number of Awards: 20
Anticipated Award Amount: $150,000 Length of Project: 3 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $150,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Anthony Campbell RPH, D.O. - Division of Pharmacologic Therapy, Center for Substance Abuse Treatment
(240) 276-2702
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
9. National Evaluation of the Technology Transfer Center Program https://www.samhsa.gov/grants/grant-announcements/ti-19-009
FOA Number: TI-19-009 Application Due Date: Friday, May 17, 2019
Description: In FY 2018, SAMHSA reconfigured its approach to training and technical assistance by establishing a
national network of regional technology transfer centers for substance abuse prevention and mental health services in
addition to the existing centers for addiction technology transfer. The fundamental premise of this new approach was the
broad dissemination of evidence-based practices to best equip the healthcare workforce with the skills needed to address
substance abuse prevention and the treatment of mental and substance use disorders whether or not this workforce was a
beneficiary of SAMHSA grant funding. The purpose of the National Evaluation is to gauge the extent to which this effort
has been effective.
Eligibility:
Domestic public and private nonprofit entities
Anticipated Total Available Funding: $750,000 Anticipated Number of Awards: One
Anticipated Award Amount: Up to $750,000 per year Length of Project: Up to 2 years
14
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $750,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information:
Program Issues
Humberto Carvalho – Office of Financial Resources
(240) 276-2974
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
10. Transforming Lives Through Supported Employment https://www.samhsa.gov/grants/grant-announcements/sm-19-011
FOA Number: SM-19-011 Application Due Date: Friday, May 17, 2019
Description: The purpose of the program is to support state and community efforts to refine, implement, and sustain
evidence-based supported employment programs and mutually compatible and supportive evidence-based practices (e.g.,
supported education) for transition-aged youth/young adults (ages 16-25) with serious emotional disturbance (SED), and
adults with serious mental illness (SMI) or co-occurring mental and substance use disorders (COD).
Eligibility:
Domestic public and private nonprofit entities
Anticipated Total Available Funding: $5,792,761 Anticipated Number of Awards: Seven
Anticipated Award Amount: $800,000 Length of Project: 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $800,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information:
Program Issues
Mary Blake - Community Support Programs Branch
Division of Services and Systems Improvement - Center for Mental Health Services
(240) 276-0625
Rachel Steidl - Community Support Programs Branch
Division of Services and Systems Improvement - Center for Mental Health Services
(240) 276-0625
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
15
(240) 276-1412
11. First Responders-Comprehensive Addiction and Recovery Act https://www.samhsa.gov/grants/grant-announcements/ti-19-004
FOA Number: TI-19-004 Application Due Date: Monday, May 6, 2019
Description: The purpose of this program is to allow first responders and members of other key community sectors to
administer a drug or device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment
of known or suspected opioid overdose. Recipients will train and provide resources to first responders and members of
other key community sectors at the state, tribal, and local governmental levels on carrying and administering a drug or
device approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or
suspected opioid overdose. Recipients will also establish processes, protocols, mechanisms for referral to appropriate
treatment and recovery communities, and safety around fentanyl, carfentanil, and other dangerous licit and illicit drugs.
For the purposes of this funding opportunity announcement (FOA), first responders include firefighters, law enforcement
officers, paramedics, emergency medical technicians, or other legally organized and recognized volunteer organizations
that respond to adverse opioid related incidents.
Eligibility:
State governments;
Federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian
Organizations, and consortia of tribes or tribal organizations; and
Local governmental entities including, but not limited to, municipal corporations, counties, cities, boroughs,
incorporated towns, and townships.
Anticipated Total Available Funding: $16.5 million Anticipated Number of Awards: Up to 45
Anticipated Award Amount: $250,000 to $800,000 per year Length of Project: Up to 4 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $250,000 - $800,000 in total costs (direct and indirect) in any year of the proposed
project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals
and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information:
Program Issues
Judith Ellis - SAMHSA/CSAP
(240) 276-2567
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
12. Minority Aids Initiative: Substance Use Disorder Treatment for Racial/Ethnic
Minority Populations at High Risk for HIV/AIDS https://www.samhsa.gov/grants/grant-announcements/ti-19-008
16
FOA Number: TI-19-008 Application Due Date: Monday, April 22, 2019
Description: The purpose of this program is to increase engagement in care for racial and ethnic minority individuals
with substance use disorders (SUD) and/or co-occurring substance use and mental disorders (COD) who are at risk for
HIV or are HIV positive that receive HIV services/treatment.
Eligibility:
Domestic public and private nonprofit entities.
Grantees that received awards under TI-17-011 in FY 2017 and FY 2018 are not eligible to apply.
Anticipated Total Available Funding: $12 million Anticipated Number of Awards: 24
Anticipated Award Amount: $500,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $500,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues Kirk James, M.D. - Center for Substance Abuse Treatment, Division of Services Improvement
(240) 276-1617
Grants Management and Budget Issues Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
13. Building Communities of Recovery
https://www.samhsa.gov/grants/grant-announcements/ti-19-003
FOA Number: TI-19-003 Application Due Date: April 2, 2019
Description: The purpose of this program is to mobilize resources within and outside of the recovery community to
increase the prevalence and quality of long-term recovery support from substance abuse and addiction. These grants are
intended to support the development, enhancement, expansion, and delivery of recovery support services (RSS) as well as
promotion of and education about recovery. Programs will be principally governed by people in recovery from substance
abuse and addiction who reflect the community served.
Grantees may use funds to: 1) build connections between recovery networks, between RCOs, and with other RSS; 2)
reduce the stigma associated with drug/alcohol addiction; and 3) conduct public education and outreach on issues relating
to drug/alcohol addiction and recovery.
Eligibility:
RCOs that are domestic private nonprofit entities in states, territories, or tribes.
Anticipated Total Available Funding: $521,000 Anticipated Number of Awards: 3
Anticipated Award Amount: $200,000 Length of Project: Up to 3 years
17
Cost Sharing/Match Required?: Yes
Proposed budgets cannot exceed $200,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.)
Contact Information:
Program Issues
Robert W. Day, MPH, MA - Center for Substance Abuse Treatment, Division of Services Improvement
(240) 276-2569
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
14. National Center of Excellence for Integrated Health Solutions https://www.samhsa.gov/grants/grant-announcements/sm-19-012
FOA Number: SM-19-012 Application Due Date: March 29, 2019
Description: The purpose of this program is to advance the implementation of high quality, evidence-based treatment for
individuals with co-occurring physical and mental health conditions, including substance use disorders. Data demonstrate
that individuals with mental health conditions are far more likely to also experience physical health conditions. The co-
occurrence of these conditions necessitates the delivery of holistic, integrated care. The goal of this grant is to ensure that
these services are provided in the most effective manner possible.
Eligibility:
Domestic public and private nonprofit entities.
Anticipated Total Available Funding: $2,000,000 Anticipated Number of Awards: One
Anticipated Award Amount: Up to $2,000,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $2,000,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Tenly Biggs - Center for Mental Health Services
(240) 276-2411
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
18
15. Strategic Prevention Framework – Partnerships for Success
https://www.samhsa.gov/grants/grant-announcements/sp-19-004
FOA Number: SP-19-004 Application Due Date: March 29, 2019
Description: The purpose of this grant program is to prevent the onset and reduce the progression of substance abuse and
its related problems while strengthening prevention capacity and infrastructure at the community level. The program is
intended to address one of the nation’s top substance abuse prevention priorities - underage drinking among persons aged
9 to 20. At their discretion, recipients may also use grant funds to target up to two additional, data-driven substance abuse
prevention priorities, such as the use of marijuana, cocaine, opioids, or methamphetamine, etc. by individuals ages 9 and
above.
Eligibility:
Local-level domestic public and private nonprofit entities.
Grant recipients who have received funding under SP-16-003 and SP-18-008 are not eligible to apply for funding
under this FOA.
States are not eligible to apply.
Anticipated Total Available Funding: Approximately $38,000,000 Anticipated Number of Awards: 127
Anticipated Award Amount: Up to $300,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $300,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Tonia F. Gray, MPH
Division of State Programs
Center for Substance Abuse Prevention
(240) 276-2492
Kameisha Bennett
Division of State Programs
Center for Substance Abuse Prevention
(240) 276-2586
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
16. Targeted Capacity Expansion: Special Projects
https://www.samhsa.gov/grants/grant-announcements/ti-19-007
FOA Number: TI-19-007 Application Due Date: March 25, 2019
Description: The purpose of this program is to develop and implement targeted strategies for substance use disorder
treatment provision to address a specific population or area of focus identified by the community. The purpose of the TCE
program is to address an unmet need or underserved population; this program aims to enable a community to identify the
19
specific need or population it wishes to address through the provision of evidence-based substance use disorder treatment
and/or recovery support services.
Eligibility:
Domestic public and private nonprofit entities.
Anticipated Total Available Funding: Approximately $8.3 million Anticipated Number of Awards: 22
Anticipated Award Amount: Up to $375,000 per year Length of Project: Up to 3 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $375,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
17. Provider’s Clinical Support System – Medication Assisted Treatment Grant
https://www.samhsa.gov/grants/grant-announcements/ti-19-005
FOA Number: TI-19-005 Application Due Date: February 26, 2019
Description: The purpose of this program is to expand the number of Drug Addiction Treatment Act (DATA) 2000
waived providers, increase understanding of the importance of medication-assisted treatment and ultimately increase
access to MAT through expanded prescribing of FDA-approved medications for the treatment of opioid use disorders.
Although the current initiative has provided multiple trainings and mentoring support, there still remains a significant
need to increase the number of healthcare providers to address the nation’s lack of adequate access to care and treatment
for opioid and other substance use disorders. The PCSS-MAT program will continue to provide up-to-date and evidence-
based information to support the training of health professionals and to address the complex issues of addiction.
Eligibility:
Limited to the national professional medical organizations authorized to carry out the training of providers
desiring to prescribe and/or dispense FDA-approved schedule III medications for addictive disorders. These
organizations are the American Society of Addiction Medicine (ASAM), the American Academy of Addiction
Psychiatry (AAAP), the American Medical Association (AMA), the American Osteopathic Academy of
Addiction Medicine (AOAAM), and the American Psychiatric Association (APA). Any of these entities may
apply individually; they may also apply as a consortium comprised of all or several of the eligible organizations.
If a consortium is formed for this purpose, a single organization in the consortium must be the legal applicant, the
recipient of the award, and the entity legally responsible for satisfying the grant requirements. If a consortium
submits an application, a written agreement must be included outlining the roles and responsibilities of each
participating national professional medical organization.
Anticipated Total Available Funding: $2,000,000 Anticipated Number of Awards: one
Anticipated Award Amount: Up to $2,000,000 per year Length of Project: Up to 3 years
20
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $2 million in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Anthony Campbell RPH, D.O. - Division of Pharmacologic Therapy, Center for Substance Abuse Treatment
(240) 276-2702
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
18. Grants to Expand Substance Abuse Treatment Capacity in Family Drug Courts
https://www.samhsa.gov/grants/grant-announcements/ti-19-001
FOA Number: TI-19-001 Application Due Date: January 4, 2019
Description: The purpose of this program is to expand substance use disorder (SUD) treatment services in existing family
treatment drug courts, which use the family treatment drug court model in order to provide alcohol and drug treatment
(including recovery support services, screening, assessment, case management, and program coordination) to parents with
a SUD and/or co-occurring SUD and mental disorders who have had a dependency petition filed against them or are at
risk of such filing. Services must address the needs of the family as a whole and include direct service provision to
children (18 and under) of individuals served by this project.
Recipients will be expected to provide a coordinated, multi-system approach designed to combine the sanctioning power
of treatment drug courts with effective treatment services promoting successful family preservation and reunification.
Priority funding should address gaps in the treatment continuum for court involved individuals who need treatment for a
SUD and/or co-occurring SUD and mental disorders while simultaneously addressing the needs of their children.
The expectations of the grant are to provide funding for FTDCs to assist participants in reducing the rates of substance
misuse, the severity of SUDs and co-occurring disorders, and decreasing out of home placements for children through
family reunification and preservation. This, in turn, should also decrease the number of parents or guardians whose
parental rights have been or will be terminated.
Eligibility:
State governments; the District of Columbia, Guam, the Commonwealth of Puerto Rico, the Northern Mariana
Islands, the Virgin Islands, American Samoa, the Federated States of Micronesia, the Republic of the Marshall
Islands, and the Republic of Palau are also eligible to apply.
Governmental units within political subdivisions of a state, such as a county, city or town.
Federally recognized American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian
Organizations, and consortia of tribes or tribal organizations.
Family treatment drug courts that received an award under TI-17-004 and TI-18-002 are not eligible to apply for
this funding opportunity.
Anticipated Total Available Funding: Up to $10,625,000 Anticipated Number of Awards: 25
Anticipated Award Amount: Up to $425,000 per year Length of Project: Up to 5 years
21
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $50,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Jon D. Berg - Center for Substance Abuse Treatment, Division of Service Improvement
(240) 276-1609
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
19. Grants to Expand Substance Abuse Treatment Capacity in Adult Treatment
Drug Courts and Adult Tribal Healing to Wellness Courts
https://www.samhsa.gov/grants/grant-announcements/ti-19-002
FOA Number: TI-19-002 Application Due Date: January 4, 2019
Description: The purpose of this program is to expand substance use disorder (SUD) treatment services in existing adult
problem solving courts, and adult Tribal Healing to Wellness courts, which use the treatment drug court model in order to
provide SUD treatment (including recovery support services, screening, assessment, case management, and program
coordination) to defendants/offenders.
Recipients will be expected to provide a coordinated, multi-system approach designed to combine the sanctioning power
of treatment drug courts with effective SUD treatment services to break the cycle of criminal behavior, alcohol and/or
drug use, and incarceration or other penalties. Applicants should propose to increase access and availability of services to
a larger number of clients increasing the number of individuals served and the gaps in the continuum of treatment for
individuals in these courts who have treatment needs for SUD and/or co-occurring substance use and mental disorders.
Grant funds must be used to serve people diagnosed with a SUD as their primary condition.
Eligibility:
State, local, and tribal governments with direct involvement with the adult treatment drug court/Tribal Healing to
Wellness Court
ATDCs and Adult Tribal Healing to Wellness Courts funded in FY 2017 under announcement TI-17-001 and FY
2018 under announcement TI-18-008 are not eligible to apply for this program.
Anticipated Total Available Funding: Up to $10,000,000 Anticipated Number of Awards: 25
Anticipated Award Amount: Up to $400,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $400,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
22
Jon D. Berg - Center for Substance Abuse Treatment, Division of Service Improvement
(240) 276-1609
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
20. Tribal Behavioral Health Grant Program
https://www.samhsa.gov/grants/grant-announcements/sm-19-005
FOA Number: SM-19-005 Application Due Date: January 4, 2019
Description: The purpose of this program is to prevent and reduce suicidal behavior and substance use, reduce the impact
of trauma, and promote mental health among American Indian/Alaska Native (AI/AN) youth through the age of 24 years.
Native Connections is intended to reduce the impact of mental and substance use disorders, foster culturally responsive
models that reduce and respond to the impact of trauma in AI/AN communities, and allow AI/AN communities to
facilitate collaboration among agencies to support youth as they transition into adulthood.
Eligibility:
American Indian/Alaska Native (AI/AN) tribes, tribal organizations, Urban Indian Organizations, or consortia of
tribes and tribal organizations.
Anticipated Total Available Funding: $12,797,090 Anticipated Number of Awards: Up to 51
Anticipated Award Amount: Up to $250,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $250,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, recipient progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Recipient awards will consist of 40 percent CMHS funding (up to $100,000) and 60 percent CSAP funding (up to
$150,000).
Contact Information:
Program Issues
Dr. Michelle Carnes - Suicide Prevention Branch,
Division of Prevention, Traumatic Stress, and Special Programs - Center for Mental Health Services
(240) 276-1869
Grants Management and Budget Issues
Office of Financial Resources, Division of Grants Management
(240) 276-1408
21. Rural Opioids Technical Assistance Grants
23
https://www.samhsa.gov/grants/grant-announcements/ti-18-022
FOA Number: TI-18-022 Application Due Date: Thursday, September 20, 2018
Description: The purpose of this program is to develop and disseminate training and technical assistance for rural
communities on addressing opioid issues affecting these communities. It is expected that grantees will facilitate the
identification of model programs, develop and update materials related to the prevention, treatment and recovery activities
for opioid use disorder (OUD), and ensure that high-quality training is provided.
Eligibility:
Existing USDA Cooperative Extensions grantees with a focus on opioids. The list of eligible applicants is in
Appendix L.
Anticipated Total Available Funding: $8,250,000 Anticipated Number of Awards: 15
Anticipated Award Amount: $550,000 per year Length of Project: Up to 2 years
Cost Sharing/Match Required? No
Proposed budgets cannot exceed $550,000 in total costs (direct and indirect) in any year of the proposed project. Annual
continuation awards will depend on the availability of funds, grantee progress in meeting project goals and objectives,
timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues: Humberto Carvalho - Center for Substance Abuse Treatment, Division of Service Improvement
(240) 276-2974
Grants Management and Budget Issues:
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
22. Center of Excellence for Protected Health Information Related to Mental and
Substance Use Disorders
https://www.samhsa.gov/grants/grant-announcements/ti-18-021
FOA Number: TI-18-021 Application Due Date: Friday, August 17, 2018
Description: The purpose of this program is to establish one National Center of Excellence to develop and disseminate
training, technical assistance, and educational resources for healthcare practitioners, families, individuals, states, and
communities on various privacy laws and regulations as they relate to information about mental and substance use
disorders. These include: the Health Insurance Portability and Accountability Act (HIPAA) and 42 CFR Part 2. The
Center will also address the intersection of these laws and regulations with other privacy laws such as the Family
Education Rights and Privacy Act (FERPA).
Although necessary for the protection of individuals, privacy regulations and laws are often complex and not easily
interpreted. These regulations often create confusion for both practitioners and those seeking/receiving treatment. In many
cases, these regulations are interpreted too stringently such that critical information from families, individuals or other
healthcare practitioners is withheld leading to potential negative consequences. This project aims to address the
24
complexity of these regulations through providing easily understood resources and training materials to simplify the
interpretation and implementation of these regulations.
Eligibility: Eligible applicants are domestic public and private nonprofit entities.
Anticipated Total Available Funding: $1,000,000 Anticipated Number of Awards: one
Anticipated Award Amount: Up to $1,000,000 per year Length of Project: Up to 5 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $1,000,000 in total costs (direct and indirect) in any year of the proposed
project. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals
and objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues: Mitchell Berger
(240) 276-1757
Grants Management and Budget Issues:
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
23. State Opioid Response Grants
https://www.samhsa.gov/grants/grant-announcements/ti-18-015
FOA Number: TI-18-015 Application Due Date: Monday, August 13, 2018
Description: The purpose of this program is to address the opioid crisis by increasing access to medication-assisted
treatment using the three FDA-approved medications for the treatment of opioid use disorder, reducing unmet treatment
need, and reducing opioid overdose related deaths through the provision of prevention, treatment and recovery activities
for opioid use disorder (OUD) (including prescription opioids, heroin and illicit fentanyl and fentanyl analogs). These
grants will be awarded to states and territories via formula. The program also includes a 15 percent set-aside for the ten
states with the highest mortality rate related to drug overdose deaths.
The program supplements activities pertaining to opioids currently undertaken by the state agency and will support a
comprehensive response to the opioid epidemic. The results of the assessments will identify gaps and resources from
which to build upon existing substance use prevention and treatment activities as well as community-based recovery
support services. Grantees will be required to describe how they will expand access to treatment and recovery support
services. Grantees will also be required to describe how they will advance substance misuse prevention in coordination
with other federal efforts. Grantees must use funding to supplement and not supplant existing opioid prevention,
treatment, and recovery activities in their state. Grantees are required to describe how they will improve retention in care,
using a chronic care model or other innovative model that has been shown to improve retention in care.
Eligibility:
The Single State Agencies (SSAs) and territories.
Tribes will be eligible to apply for opioid response funding under a separate announcement.
Anticipated Total Available Funding: $930,000,000 (This includes 15% set-aside for the ten states hardest hit by the
crisis).
25
Anticipated Number of Awards: 59
Anticipated Award Amount: See Appendix K for distribution Length of Project: Up to 2 years
Cost Sharing/Match Required? No
State allocations for the Opioid SOR grants are calculated by a formula based on the equal weighting of two elements: the
state’s proportion of people with abuse or dependence on opioids (prescription opioids and/or heroin) who need but do not
receive treatment (NSDUH, 2015-2016) and the state’s proportion of drug poisoning (overdose) deaths (CDC National
Vital Statistics System, 2016). Each State, as well as the District of Columbia, will receive not less than $4,000,000.
Each territory will receive not less than $250,000. See Appendix K for more information. In addition to this base
distribution, $142.5 million in funding is being distributed to the ten states with the highest mortality rates due to drug
poisoning deaths. This set-aside takes into account the state’s ordinal ranking in the top ten; it is not distributed equally
among the ten states.
Annual continuation awards will depend on the availability of funds, recipient progress in meeting project goals and
objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Grants Management and Budget Issues
24. Prevention Technology Transfer Centers Cooperative Agreements
https://www.samhsa.gov/grants/grant-announcements/sp-19-001
FOA Number: SP-19-001 Application Due Date: Tuesday, July 10, 2018
Description: The purpose of this program is to establish a PTTC Network to provide training and technical assistance
services to the substance abuse prevention field including professionals/pre-professionals, organizations, and others in the
prevention community. The PTTCs will work directly with SAMHSA and across the PTTC Network on activities aimed
at improving implementation and delivery of effective substance abuse prevention interventions. PTTCs will provide
prevention skills trainings and technical assistance services that are: tailored to meet the needs of recipients and the
prevention field; based in prevention science and use evidence-based and promising practices; and leverage the expertise
and resources available through the alliances formed within and across the HHS regions and the PTTC network.
Eligibility:
Domestic public and private not-for-profit entities
Anticipated Total Available Funding: $7.5 million Anticipated Number of Awards: 13
Award Amount: From $500,000 to $600,000 per year Length of Project: Up to five years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed the estimated award amounts listed above in total costs (direct and indirect) in any year
of the proposed project. Funding estimates for this announcement are based on the Consolidated Appropriations Act,
2018. Annual continuation awards will depend on the availability of funds, grantee progress in meeting project goals and
objectives, timely submission of required data and reports, and compliance with all terms and conditions of award.
• Up to $500,000 per year for the PTTC National Coordinating Center
• Up to $600,000 per year for each of the PTTC Regional Centers
26
• Up to $500,000 per year for the PTTC Tribal Affairs Center
• Up to $500,000 per year for the PTTC Hispanic and Latino Center
Contact Information:
Program Issues
Humberto Carvalho - Office of Financial Resources, Office of Management, Analysis, and Coordination
(240) 276-2974
Grants Management and Budget Issues
Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
25. Opioid State Targeted Response Technical Assistance
https://www.samhsa.gov/grants/grant-announcements/sm-18-019
FOA Number: SM-18-019 Application Due Date: Monday, July 9, 2018
Description: The purpose of this program is to increase access to and improve the quality of community behavioral health
services through the expansion of CCBHCs. CCBHCs provide person- and family-centered services and are available in
the 24 states that participated in the FY 2016 Planning Grants for Certified Community Behavioral Health Clinics (SM-
16-001). The CCBHC Expansion grant program must provide access to services for individuals with serious mental illness
(SMI) or substance use disorders (SUD), including opioid disorders; children and adolescents with serious emotional
disturbance (SED); and individuals with co-occurring disorders (COD). The expectation is that this program will improve
the behavioral health of individuals across the nation by providing comprehensive community-based mental and substance
use disorder services; treatment of co-occurring disorders; advance the integration of behavioral health with physical
health care; assimilate and utilize evidence-based practices on a more consistent basis, and promote improved access to
high quality care.
Eligibility:
Certified community behavioral health clinics or community-based behavioral health clinics who may not yet be
certified but meet the certification criteria and can be certified within 4 months of award in the following states:
AK, CA, CO, CT, IA, IL, IN, KY, MA, MD, MI, MN, MO, NC, NJ, NM, NV, NY, OK, OR, PA, RI, TX, and
VA.
Anticipated Total Available Funding: $47,951,359 Anticipated Number of Awards: Up to 25
Anticipated Award Amount: Up to $2,000,000 annually Length of Project: Up to 2 years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $2,000,000 in total costs (direct and indirect) in any year of the proposed project.
Funding estimates for this announcement are based on the Consolidated Appropriations Act, 2018. Annual continuation
awards will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely
submission of required data and reports, and compliance with all terms and conditions of award.
Contact information:
Program Issues
Joy Mobley, Psy.D. - Community Support Programs Branch
Division of Service and Systems Improvement - Center for Mental Health Services
(240) 276-2823
27
Grants Management and Budget Issues
Gwendolyn Simpson - Office of Financial Resources - Division of Grants Management
(240) 276-1408
26. Targeted Capacity Expansion: Medication Assisted Treatment – Prescription
Drug and Opioid Addiction
https://www.samhsa.gov/grants/grant-announcements/ti-18-009
FOA Number: TI-18-009 Application Due Date: Monday, July 9, 2018
Description: The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services
for persons with an opioid use disorder (OUD) seeking or receiving MAT. This program’s focus is on funding
organizations and tribes/tribal organizations within states identified as having the highest rates of primary treatment
admissions for heroin and opioids per capita and includes those states with the most dramatic increases for heroin and
opioids, based on SAMHSA’s 2015 Treatment Episode Data Set (TEDS). The desired outcomes include: 1) an increase
in the number of individuals with OUD receiving MAT 3) a decrease in illicit opioid drug use and prescription opioid
misuse at six-month follow-up.
Eligibility:
Domestic states, political subdivisions within states, and public and private nonprofit organizations in states with
the highest rates of primary treatment admissions for heroin and opioids per capita and includes those with the
most dramatic increases for heroin and opioids, as identified by SAMHSA’s 2015 Treatment Episode Data Set
(TEDS).
Tribes/tribal organizations across the United States are also eligible to receive funding.
Anticipated Total Available Funding: $65,583,803 (At least $5 million will be awarded to federally recognized
American Indian/Alaska Native (AI/AN) tribes/tribal organizations) Anticipated Number of Awards: Up to 125
Anticipated Award Amount: Up to $524,670 per year Length of Project: Up to three years
Cost Sharing/Match Required?: No
Proposed budgets cannot exceed $524,670 in total costs (direct and indirect) in any year of the proposed project. Funding
estimates for this announcement are based on the Consolidated Appropriations Act, 2018. Annual continuation awards
will depend on the availability of funds, recipient progress in meeting project goals and objectives, timely submission of
required data and reports, and compliance with all terms and conditions of award.
Contact Information:
Program Issues
Kim Thierry-English - Center for Substance Abuse Treatment, Division of Services Improvement
(240) 276-2907
Grants Management and Budget Issues Eileen Bermudez - Office of Financial Resources, Division of Grants Management
(240) 276-1412
Listing of Grant Drug-Treatment Related Postings through the U.S. Department of Health & Human Services Health
Resources & Services Administration
28
CURRENT FUNDING PROGRAMS THROUGH HRSA:
There are currently no funding programs offered through HRSA related to substance use disorder.
PAST FUNDING PROGRAMS THROUGH HRSA:
27. Rural Communities Opioid Response Program – Assisted Treatment Expansion
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b78be3df-ea8f-40b0-82b4-ba0c0857030c
Funding Opportunity Number: HRSA-19-102
Application Deadline: 06/18/2019 Projected Award Date: 09/01/2019
Program Description: This funding opportunity will advance RCORP’s overall goal by establishing and/or expanding
MAT in eligible hospitals, health clinics, or tribal organizations in high-risk rural communities. RCORP-MAT Expansion
aims to increase the number of access points where individuals living in rural communities with OUD can receive
evidence-based treatment. Additionally, recognizing that MAT patients may have other clinical and social service needs,
RCORP-MAT Expansion requires that eligible entities provide and/or coordinate complementary services (e.g., provision
of or referral to other SUD/OUD and mental health services, assistance with transportation, etc.), as outlined in the
Program-Specific Instructions section of this NOFO.
Additional Eligibility:
Eligible entities include critical access hospitals, rural health clinics, other small rural hospitals with 49 available staffed
beds or less, as reported on the hospital’s most recently filed Medicare Cost Report; Health Center Look Alikes; and tribes
or tribal organizations. Applicants must be located in a HRSA-designated rural area.
Contact Information:
Kiley Diop
(301) 443-6666
28. Rural Communities Opioid Response Program – Rural Centers of Excellence on
Substance Use Disorders
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3df1746a-314c-4581-a570-940058b6b849
Funding Opportunity Number: HRSA-19-108
Application Deadline: 06/10/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of RCORP-RCOE is to support the identification, translation, dissemination, and
implementation of evidence-based programs and best practices “related to the treatment for and prevention of substance
use disorders within rural communities, with a focus on the current opioid crisis and developing methods to address future
substance use disorder epidemics.” 1) The Centers will engage in research to identify “science-based prevention,
treatment, and other risk reduction interventions, including community-based approaches that may be replicable in other
rural communities and associated professional training.” 2) After identifying rural-relevant interventions, the Centers will
serve as a resource for “scientific and technical assistance to county and state health departments and other entities as
identified seeking guidance on how to address the substance use disorder challenges in their community.” 3) Other such
29
entities in rural communities may include, but are not limited to, state offices of rural health (SORHs), critical access
hospitals (CAHs), rural health clinics (RHCs), and other rural health care providers. Training and technical assistance
(TA) should help rural communities translate best practices to their unique community settings and implement those
practices to reduce the morbidity and mortality related to SUD, particularly OUD, in their area. Over the three-year period
of performance, the Centers should demonstrate how scientific and technical assistance and professional training related
to evidence-based SUD interventions can improve prevention, treatment, and recovery in rural communities, with a focus
on OUD. The Centers should also demonstrate how their programming improves health and other outcomes as well as
systems for addressing current and future SUD epidemics in rural communities.
Additional Eligibility:
Eligible applicants include all domestic public or private, non-profit or for-profit entities, including state, county, or city
or township governments; independent school districts; public housing authorities or Indian housing authorities; public or
private institutions of higher education; small businesses; faith-based and community-based organizations; and federally
recognized tribes, tribal organizations, and tribal governments; or consortia of these organizations.
Contact Information:
Aaron Beswick
(312) 353-7214
29. Fiscal Year (FY) 2019 Integrated Behavioral Health Services (IBHS)
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=a238fc24-7a74-4c8f-8455-7b2e18e9e817
Funding Opportunity Number: HRSA-19-100
Application Deadline: 05/20/2019 Projected Award Date: 09/01/2019
Program Description: This supplemental funding opportunity for existing Health Center Program (H80) award recipients
will increase access to high quality integrated behavioral health services, including prevention or treatment of mental
health conditions and/or substance use disorders, including opioid use disorder.
Additional Eligibility:
Organizations receiving Health Center Program operational grant (H80) funding at the time of this funding opportunity
release are eligible to apply.
Contact Information:
Rael Ammon
(301) 594-4300
30. Opioid Workforce Expansion Program (OWEP) Paraprofessionals
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b46a08de-2bc2-421f-8b5e-71de9cc9b17d
Funding Opportunity Number: HRSA-19-089
Application Deadline: 05/07/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of this program is to enhance community-based experiential training for students
preparing to become peer support specialists and other types of behavioral health-related paraprofessionals with a focus
on Opioid Use Disorder (OUD) and other Substance Use Disorders (SUD) prevention, treatment and recovery services.
30
Consistent with the statutory authority, applicants must also demonstrate a special focus on preservice or in-service
training of paraprofessional child and adolescent mental health workers to understand the specific concerns of children,
adolescents, and transitional-age youth in high need and high demand areas who are at risk for behavioral health
disorders. The program is designed to expand and improve direct access to quality treatment and foster an integrated
and/or interprofessional approach to address OUD and other SUD treatment emphasizing the role of the family and lived
experience of the consumer through academic, community and non-traditional community organization partnerships. The
program also supports career development in behavioral health for paraprofessional career progression as well as the
development of skills and expertise of staff, facilitators, and training instructors in prevention, treatment, and recovery
services of OUD and other SUDs. Award recipients will impact the behavioral health workforce by increasing the number
of behavioral health-related paraprofessionals and transforming integrated and interprofessional teams to effectively
prevent and treat OUD and other SUDs in community-based practices.
Additional Eligibility:
State-licensed mental health nonprofit and for-profit organizations. These organizations must be able to carry out
programs for pre-service or in-service training of paraprofessional child and adolescent mental health workers. These
programs can include occupations such as peer support specialist, peer support counselor, community health worker,
outreach worker, social services aide, substance abuse/addictions worker, youth worker, and promotor/a (for full list of
occupations see the definitions section). For the purpose of this NOFO, these organizations may include academic
institutions, including universities, community colleges and technical schools, which must be accredited by a nationally
recognized accrediting agency, as specified by the U.S. Department of Education. Tribal Organizations may apply for this
these funds, if otherwise eligible. In addition to the 50 states, eligible entities include the District of Columbia, Guam, the
Commonwealth of Puerto Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated
States of Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.
Contact Information:
Nicole M. Wilkerson
(301)443-6666
31. Opioid Workforce Expansion Program (OWEP) Professionals
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=b46a08de-2bc2-421f-8b5e-71de9cc9b17d
Funding Opportunity Number: HRSA-19-085
Application Deadline: 05/07/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of this program is to enhance community-based experiential training for students
preparing to become behavioral health professionals with a focus on Opioid Use Disorder (OUD) and other Substance Use
Disorders (SUD) prevention, treatment, and recovery services. The program will provide funding for training behavioral
health professionals in the provision of OUD and other SUD prevention, treatment, and recovery services in high need
and high demand areas. The program also supports the development of behavioral health faculty skills and expertise in the
prevention, treatment, and recovery of patients with OUD and other SUD. Award recipients will impact the quality and
access to behavioral health and substance use services in high need and high demand areas by increasing the number of
professionals and transforming integrated behavioral health and primary care teams to effectively prevent and treat OUD
and other SUD in community-based practices.
Additional Eligibility:
Accredited institutions of higher education or accredited behavioral health professional training programs. These
programs can include psychiatry, psychology, school psychology, behavioral pediatrics, psychiatric nursing, social work,
school social work, SUD prevention and treatment, marriage and family therapy, occupational therapy, school counseling,
or professional counseling. To ensure students are prepared to enter the workforce immediately upon graduation,
31
programs must require a pre-degree clinical field placement in behavioral health as part of the training and a prerequisite
for graduation.
Accredited masters or doctoral-level programs in social work.
American Psychology Association (APA)-accredited doctoral, internship and post-doctoral residency programs of
psychology and health service psychology (including clinical psychology, counseling and school psychology)
programs in practice psychology.
Domestic faith-based and community-based organizations and tribal organizations are also eligible to apply, if
otherwise eligible.
In addition to the 50 states, eligible entities include the District of Columbia, Guam, the Commonwealth of Puerto
Rico, the Northern Mariana Islands, American Samoa, the U.S. Virgin Islands, the Federated States of
Micronesia, the Republic of the Marshall Islands, or the Republic of Palau.
Contact Information:
Andrea G. Battle, Ph.D.
(301) 443-1928
32. Graduate Psychology Education (GPE) Program
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=56c79f3f-e00c-453d-bed4-f4ae55aaf4bc
Funding Opportunity Number: HRSA-19-002
Application Deadline: 05/07/2019 Projected Award Date: 07/01/2019
Program Description: The purpose of this program is to train doctoral health psychology students, interns, and post-
doctoral residents to provide integrated, interdisciplinary, behavioral health and Opioid Use Disorder (OUD) and other
Substance Use Disorder (SUD) prevention and treatment services in high need and high demand areas. The program also
supports faculty development of health service psychology. For purposes of this NOFO, high need and high demand areas
are identified by two defined sources:
County of experiential training site location has less than 10 licensed psychologists per 100,000 population as
found in the APA County Level Analysis of US Licensed Psychologists
Experiential training site is located in a Mental Health Professional Shortage Areas (HPSAs) or that are Facility
Mental HPSAs with a score of 16 or above as found in the HPSA Find Tool.
The overarching goal of the program is to prepare and build capacity of the doctoral health psychology workforce, to
provide mental/behavioral health care, including OUD and other SUD prevention and treatment services, in high need and
high demand areas.
Additional Eligibility:
Eligible entities are APA-accredited doctoral schools and programs of health service psychology, APA-accredited
doctoral internships in professional psychology, and APA-accredited post-doctoral residency programs in practice
psychology.
Contact Information:
Andrea G. Battle, Ph.D.
(301) 443-1928
33. Rural Communities Opioid Response Program-Implementation
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=7afdb9d3-f7e5-484a-9c91-618e809c6005
32
Funding Opportunity Number: HRSA-19-082
Application Deadline: 05/06/2019 Projected Award Date: 09/01/2019
Program Description: The Rural Communities Opioid Response Program (RCORP) is a multi-year opioid-focused
initiative by the Health Resources and Services Administration (HRSA) aimed at reducing the morbidity and mortality of
substance use disorder (SUD), including opioid use disorder (OUD), in rural communities at the highest risk for SUD.
This notice announces the opportunity to apply for funding under the RCORP-Implementation. RCORP-Implementation
will advance RCORP’s overall goal by strengthening and expanding SUD/OUD prevention, treatment, and recovery
service delivery in high-risk rural communities. By expanding the options for SUD/OUD services across the care
spectrum, RCORP-Implementation will help rural residents access treatment and move towards recovery. In 2017, the
U.S. Department of Health and Human Services (HHS) initiated a comprehensive effort to empower local communities to
combat the opioid crisis through a Five-Point Strategy. In alignment with the HHS Five-Point Strategy, and as part of
RCORP, RCORP-Implementation award recipients will implement robust, evidence-based interventions and promising
practice models to expand access to, and strengthen the quality of, SUD/OUD prevention, treatment, and recovery
services in high-risk rural communities.
You are required to align your application with the following RCORP-Implementation focus areas:
a. Prevention: Reducing the occurrence and associated risk of OUD among new and at-risk users (including
polysubstance users), as well as fatal opioid-related overdoses, and promoting infectious disease detection through
activities such as community and provider education, harm reduction strategies, and referral to treatment and
recovery support services.
b. Treatment: Implementing or expanding access to evidence-based practices, including medication-assisted
treatment (MAT) with psychosocial intervention, and eliminating or reducing treatment costs for uninsured and
underinsured patients.
c. Recovery: Implementing or expanding access to recovery and treatment options that help people battling OUD
(including those with polysubstance disorders) start and stay in recovery, including ensuring access to support
services such as, but not limited to, transportation, housing, peer recovery, case management, employment
assistance, and child care.
HRSA envisions that award recipients will sustain programs beyond the three-year period of performance. In particular, it
is expected that RCORP-Implementation award recipients will:
Leverage other available opioid resources at the federal, state and local levels to maximize program impact
Expand the ability of providers to bill for treatment services
Monitor and evaluate the impact and outcomes of SUD/OUD prevention, treatment, and recovery activities
Develop a long-term strategy to achieve financial and operational sustainability absent federal funding and
address the future needs of the community.
In FY 2019, HRSA will provide support for additional programs to improve access to prevention, treatment, and recovery
support services in rural communities, including additional RCORP-Planning grants and National Health Service Corps
(NHSC) Loan Repayment Program (LRP) awards.
Additional Eligibility:
Eligible applicants include all domestic public or private, non-profit or for-profit entities, including faith-based and
community-based organizations, tribes, and tribal organizations and should serve rural communities at the highest risk for
SUD. All activities supported by RCORP-Implementation must exclusively target populations residing in HRSA-
designated rural counties or rural census tracts in urban counties (as defined by the Rural Health Grants Eligibility
Analyzer). HRSA-19-082 4 The applicant organization may be located in an urban or rural area and should have the
staffing and infrastructure necessary to oversee program activities, serve as the fiscal agent for the award, and ensure that
local control for the award is vested in the targeted rural communities.
33
Contact Information:
Allison Hutchings
(301) 945-9819
34. Rural Communities Opioid Response Program-Evaluation
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=3928c5b9-8c40-45a7-81b2-88c835bc5e09
Funding Opportunity Number: HRSA-19-083
Application Deadline: 05/06/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of this cooperative agreement is to evaluate the impact of Rural Community Opioid
Response Program (RCORP) initiatives which currently include the RCORP-Planning, RCORP-Implementation, and
RCORP-Technical Assistance (RCORP-TA) activities, and to develop valuable RCORP-based evaluation tools and
resources for use in rural communities and to inform future rural health initiatives. Working with all RCORP award
recipients, the RCORP-Evaluation anticipated activities include collecting and analyzing award recipient-reported data,
defining and implementing impact indicators to assess the effectiveness of TA and award recipient activities, working
with the RCORP-TA provider to identify RCORP best practices, using RCORP findings to identify research needs, and
making recommendations to enhance RCORP activities and inform future rural health initiatives.
Additional Eligibility:
Eligible applicants include domestic public or private, non-profit or for-profit organizations. Institutions of higher
education, faith-based and community-based organizations, tribes, and tribal organizations are eligible to
apply. Applicants may be a single entity or a consortium.
Contact Information:
Fraser Byrne
(301) 443-2299
35. Small Health Care Provider Quality Improvement Program
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=00ba519a-3f47-4987-99ba-b1d443cf8097
Funding Opportunity Number: HRSA-19-018
Application Deadline: 04/22/2019 Projected Award Date: 08/01/2019
Program Description: The purpose of the Rural Quality Program is to support planning and implementation of quality
improvement activities for rural primary care providers or providers of health care services, such as a critical access
hospital or a rural health clinic, serving rural residents. These activities include providing clinical health services to
residents of rural areas by funding projects that coordinate, expand access, contain costs, and improve the quality of
essential health care services. The program goal is to promote the development of an evidence-based quality improvement
culture and to promote the delivery of cost-effective, coordinated health care services in primary care settings.
Successfully funded projects will enhance the delivery of health care in rural areas and demonstrate improvements in:
1) Patient health outcomes for the rural communities served
2) The delivery and quality of essential rural health care services by the end of the three-year period of
performance.
34
Additional objectives of the program include enhanced chronic disease management and increased engagement of patients
and their caregivers. The FY 2019 Rural Quality Program additionally requests project proposals focus on rural chronic
disease management and/or the integration of mental/behavioral health services into the rural primary care setting.
Although it is not a requirement, HRSA strongly encourages applicants to form a consortium or network for this program.
Awarded organizations are not required to, but are permitted, to use funds to obtain or maintain nationally recognized.
Additional Eligibility:
Eligible applicants must be a rural public or rural nonprofit private health care provider or provider of health care services,
such as a critical access hospital or a rural health clinic; or network of small rural providers; and must not previously have
received an award under this subsection for the same or similar project. For the purposes of this program, “health care
provider” may include, but is not limited to, entities such as black lung clinics, hospitals, public health agencies, home
health providers, mental health centers and providers, substance abuse service providers, rural health clinics, primary care
providers, oral health providers, social service agencies, health profession schools, local school districts, emergency
services providers, community health centers/federally qualified health centers, tribal health programs, churches, and civic
organizations that are providing health care services.
Contact Information:
Katherine Lloyd
(301) 443-2933
36. Strengthening Systems of Care for People Living with HIV and Opioid Use
Disorder
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=e10984ec-f552-4caf-a3b4-0283d5470520
Funding Opportunity Number: HRSA-19-038
Application Deadline: 04/16/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of this initiative is to fund an estimated one (1) to four (4) entities, referred to as
System Coordination Providers (SCPs), who will assist states in leveraging resources at federal, state, and local levels for
people living with HIV (PLWH) and opioid use disorder (OUD). Specifically, the goal of this initiative is to strengthen
system-level coordination and networks of care between the Ryan White HIV/AIDS Program (RWHAP) recipients and
other federal, state and local entities funded to respond to the opioid epidemic to ensure PLWH and OUD have access to
behavioral health (BH) care, treatment, and recovery services.
This will be accomplished by identifying new and expanded resources to treat persons with OUD, identifying new and
existing partners in the system of care, and building and strengthening networks of care between the RWHAP and entities
receiving OUD-focused resources. This initiative will strengthen and build upon existing systems of care and treatment
that will maximize cross-sector collaboration across federal, state, and local partners in order to achieve improvements in
the system-level coordination and leveraging of available resources for improving the health outcomes of PLWH and
OUD.
The SCP(s) awarded under this initiative will be responsible for implementing a system-wide assessment of OUD care
and treatment, if none is available, and identifying the availability of resources at the federal, state, and local levels to
combat the national opioid epidemic. The SCP(s) will assist RWHAP providers in leveraging the use of these resources
for the care and treatment of OUD in PLWH, and should capitalize on what has already been done, if relevant. The
SCP(s) will ultimately enhance the capacity of these organizations to capitalize on resources directed at addressing the
opioid epidemic to improve BH treatments among PLWH and OUD.
35
Additional Eligibility:
Entities eligible for funding under Parts A – D of Title XXVI of the Public Health Service Act as amended by the Ryan
White HIV/AIDS Treatment Extension Act of 2009, including public health departments and institutions of higher
education, state and local governments, nonprofit organizations, faith-based and community-based organizations, tribes
and tribal organizations are eligible to apply.
Contact Information:
Adan Cajina
(301) 443-3180
37. Rural Residency Planning and Development Program
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=bd0f561a-78b7-4053-a06f-722afa117f31
Funding Opportunity Number: HRSA-19-088
Application Deadline: 03/25/2019 Projected Award Date: 08/01/2019
Program Description: The purpose of this grant program is to develop new rural residency programs or Rural Training
Tracks (RTT) in family medicine, internal medicine, and psychiatry, to support expansion of the physician workforce in
rural areas. The new rural residency programs or RTTs are intended to be sustainable through separate public or private
funding beyond the RRPD grant period of performance.
Rural residency programs are allopathic and osteopathic physician residency training programs that primarily train in rural
communities, place residents in rural locations for greater than 50 percent of their training, and focus on producing
physicians who will practice in rural communities. A common model is the RTT, where the first year of training occurs
within a larger program in an urban academic medical center and the final two years occur in a rural facility.
Additional Eligibility:
Eligible applicants are: 1) rural hospitals, 2) rural community-based ambulatory patient care centers, including federally
qualified health centers, community mental health centers or rural health clinics, 3) health centers operated by the Indian
Health service, an Indian tribe or tribal organization, or an urban Indian organization; 4) schools of allopathic medicine or
osteopathic medicine, 5) public or private non-profit graduate medical education consortiums 6) entities such as faith-
based and community-based organizations, capable of carrying out the grant activities.
If the applicant’s sustainability plan is to obtain Medicare graduate medical education payments, the applicant
organization must be a rural hospital in accordance with Medicare regulations. Eligible applicants must be located in a
rural location. In the case of a consortium, a school of allopathic medicine or osteopathic medicine, or other public or non-
profit entity, eligible applicants must have a primary training partner (where resident training will occur primarily or
exclusively) located in a rural area.
Contact Information:
Tracey Smith
(301) 443-3612
38. Rural Health Innovation and Transformation Technical Assistance
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=5fbf826f-13dd-4dd2-95b7-f15151fd5599
Funding Opportunity Number: HRSA-19-022
36
Application Deadline: 02/22/2019 Projected Award Date: 08/01/2019
Program Description: The purpose of this program is to provide technical assistance (TA) to rural stakeholders and the
public to help them understand and engage in the value-based care landscape in the context of rural health care.
In an effort to control health care costs and improve the quality of care, public and private payers have increasingly
implemented initiatives to encourage value-based care. Value-based care programs reward health care providers for the
quality of care through the realignment of financial incentives towards value over volume. Because of the unique
economic factors affecting rural providers, the implementation and effects of value-based care initiatives may look
different in rural, low-volume settings. For example, low patient volumes, along with low margins, in rural settings can
make it more difficult to absorb the financial risks associated with value-based care. Start-up costs for value-based care
may seem prohibitive for some, while small volumes may make it more difficult to measure value and may increase the
risk of skewed outcomes. At the same time, value-based care initiatives are evolving towards risk-based models, and there
is a need to help stakeholders and the public understand how these changes affect rural health care. Therefore, a major
goal of this funding opportunity is to support the ability of rural providers to participate and succeed in current and
emerging payment and delivery system models designed to provide value-based care.
Additional Eligibility:
Eligible applicants include domestic public, private, and non-profit organizations, including tribes and tribal
organizations, and domestic faith-based and community-based organizations
Contact Information:
Kerri Cornejo
(301) 443-4204
39. U3D Maternal and Child Health Measurement Research Network (MRN)
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=ad02b5d6-6f67-4f0b-b8a5-b5d89492fb11
Funding Opportunity Number: HRSA-19-071
Application Deadline: 02/15/2019 Projected Award Date: 09/01/2019
Program Description: The purpose of this program is to coordinate a national platform to recruit, convene, and actively
engage researchers and family members to identify and fill gaps in existing MCH measures. This national MRN is an
interdisciplinary Research Network focused on supporting, optimizing, and centralizing MCH-related health measurement
research (hereafter referred to as “the Network”).
The Network should prioritize the identification, development, dissemination, and cross disciplinary adoption of measures
to address gaps in the following topical areas: family engagement, adequacy of pediatric health care utilization,[1] parent-
infant dyadic relational health,[2] positive child health and wellbeing,[3] and measures related to maternal morbidity and
mortality.[4] Reliable, validated measures on these topical areas are important in addressing health disparities and
improving health outcomes for MCH populations. The Network should incorporate relevant HRSA priorities that are
aligned with Title V Maternal and Child Health Block Grant national performance measures, including opioid and
substance use disorder, mental health, maternal morbidity/mortality, and/or childhood obesity. The Network should
provide quantifiable evidence and metrics demonstrating the adoption of the developed and/or validated measures by
diverse stakeholders.
Additional Eligibility:
Eligible applicants include domestic public or non-profit institutions of higher learning and public or private non-profit
agencies engaged in research or in programs relating to maternal and child health and/or services for children with special
37
health care needs are eligible to apply. Domestic faith-based and community-based organizations, tribes, and tribal
organizations are also eligible to apply, if they otherwise meet these eligibility criteria.
Contact Information:
Evva Assing-Murray, Ph.D., MA
(301) 594-4113
40. Small Rural Hospital Improvement Program
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=c373380d-bd12-47d7-82b4-6c0466b5c766
Funding Opportunity Number: HRSA-19-020
Application Deadline: 01/30/2019 Projected Award Date: 06/01/2019
Program Description: This notice announces the opportunity to apply for funding under the Small Rural Hospital
Improvement Program (SHIP). This program supports eligible hospitals in meeting value-based payment and care goals
for their respective organizations, through purchases of hardware, software and training. SHIP also enables small rural
hospitals: to become or join accountable care organizations (ACOs); to participate in shared savings programs; and to
purchase health information technology (hardware and software), equipment, and/or training to comply with quality
improvement activities, such as advancing patient care information, promoting interoperability, and payment bundling.
Additional Eligibility:
The SORH will be the official award recipient acting as fiscal intermediary for all hospitals within its state. Eligible
applicants include states that are currently SHIP recipients, as well as states with hospitals that meet eligibility
requirements yet have not been previously funded. SHIP funds assist eligible small rural hospitals that are essential access
points for Medicare and Medicaid beneficiaries. Eligible small rural hospitals are non-federal, short-term general acute
care facilities that are located in a rural area of the U.S. and the territories, including faith-based hospitals.
For the purpose of this program: 1) "eligible small rural hospital" is defined as a non-federal, short-term general acute care
hospital 2) "rural area" is defined as either located outside of a Metropolitan Statistical Area, located within a rural census
tract of a MSA, or is being treated as if being located in a rural area 3) Eligible SHIP hospitals may be for-profit or not-
for-profit, including faith-based.
Contact Information:
Jeanene Meyers
(301) 443-2482
41. Rural Health Network Development Planning Program
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=820ff0a2-594f-4944-81b4-54365531cab1
Funding Opportunity Number: HRSA-19-025
Application Deadline: 11/30/2018 Projected Award Date: 07/01/2019
Program Description: The purpose of the Network Planning program is to assist in the development of an integrated
health care network, specifically network participants who do not have a history of formal collaborative efforts in order to:
38
(i) achieve efficiencies; (ii) expand access to, coordinate, and improve the quality of essential health care services; and
(iii) strengthen the rural health care system as a whole.
Additional Eligibility:
The applicant organization must be a rural nonprofit private or rural public entity that represents a consortium/network
composed of three or more health care providers. Federally-recognized tribal entities are eligible to apply as long as they
are located in a rural area. The applicant organization must be located in a non-metropolitan county or in a rural census
tract of a metropolitan county, and all services must be provided in a non-metropolitan county or rural census tract.
Contact Information:
Sara Afayee
(301) 945-4169
42. Rural Communities Opioid Response Program – Technical Assistance
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=35ee358e-d42f-4c7a-ba6e-d71f228eb1a9
Funding Opportunity Number: HRSA-18-124 Application Deadline: 08/10/2018
Description: The purpose of this cooperative agreement is to provide technical assistance (TA) support for rural
communities engaging in activities to combat opioid use disorder (OUD). The TA efforts will enhance the organizational
and infrastructural capacity of multi-sector consortiums at the community, county, state, and/or regional levels. The
overall goal is the reduction of morbidity and mortality associated with opioid overdoses in high-risk rural communities.
The RCORP -TA award recipient will provide resources and expertise in support of the execution of the following focus
areas:
Prevention: reducing the occurrence of OUD among new and at-risk users as well as fatal opioid-related
overdoses through community and provider education and harm reduction measures including the strategic
placement of overdose reversing devices, such as naloxone;
Treatment: implementing or expanding access to evidence-based practices for opioid addiction/OUD treatment
such as medication-assisted treatment (MAT), including developing strategies to eliminate or reduce treatment
costs to uninsured and underinsured patients
Recovery: expanding peer recovery and treatment options to help people start and stay in recovery.
The RCORP-TA initiative is part of a multi-year, $130.0 million opioid focused effort by HRSA that will include:
improving access to and recruitment of new substance use disorder providers; building sustainable treatment resources;
increasing the use of telehealth; establishing cross-sector community partnerships; implementing new models of care,
including integrated behavioral health; and providing technical assistance. The RCORP -TA award recipient will provide
in-depth TA for planning and implementation to HRSA’s Rural Communities Opioid Response Program award recipients.
In FY 2019 and beyond, there will be additional funds available to provide continued support, including additional grants
and National Health Service Corps (NHSC) Loan Repayment Program awards. RCORP award recipients and the
communities they serve will receive tailored TA that may include, but is not limited to, the following:
Developing and implementing a strategic plan for the provision of TA to consortiums that are funded by HRSA
through the RCORP grants
Synthesizing resources for the development and strengthening of consortiums; HRSA-18-124 2
Developing training and tools to support analysis of opportunities and gaps in the workforce and service delivery
(to include telehealth) associated with OUD prevention, treatment, and recovery
Developing training and tools to educate RCORP award recipients and facilitate their strategic plan development
addressing gaps in OUD prevention, treatment, and recovery
Identifying and developing training and tools associated with workforce recruitment and retention targeted to
rural communities to build provider capacity to address OUD issues
39
Assisting RCORP award recipients in collaborating with the National Health Service Corps (NHSC) to recruit
providers
Assisting with the identification and development of evidence-based practice models relating to OUD prevention,
treatment, and recovery
Assisting with the identification and development of sustainability practices for consortiums
Assisting with the identification and development of program measures for award recipients for the RCORP
grants
Assisting in building consortiums’ capacity and infrastructure to collect data to participate in program-wide
evaluation activities
Educating RCORP award recipients about other available federal and non-federal funding and resources to
prepare them to leverage those resources, aid coordination, and avoid duplication of program efforts
Educating rural stakeholders of national and state laws associated with OUD prevention,
Additional Eligibility: Eligible applicants include domestic public or private, non-profit entities. Domestic faith-based
and community-based organizations, tribes, and tribal organizations are also eligible to apply.
Contact Information:
Michael McNeely
(301) 443-5812
43. Rural Communities Opioid Response Program - Planning
https://www.hrsa.gov/grants/fundingopportunities/default.aspx?id=35ee358e-d42f-4c7a-ba6e-d71f228eb1a9
Funding Opportunity Number: HRSA-18-116 Application Deadline: 08/03/2018
Description: This notice solicits applications for the Rural Communities Opioid Response Program- Planning (RCORP-
Planning). The purpose of RCORP is to support treatment for and prevention of substance use disorder, including opioid
use disorder, in rural counties at the highest risk for substance use disorder, including the 220 counties identified by the
Centers for Disease Control and Prevention (CDC) as being at risk for HIV and Hepatitis C infections due to injection
drug use (See Appendix A for additional eligibility information).
Additional Eligibility: Eligible applicants include all domestic public or private, non-profit or for-profit, entities,
including faith-based and community-based organizations, tribes, and tribal organizations, who will serve rural
communities at the highest risk for substance use disorder and who meet the RCORP-Planning specifications for the
Applicant Organization and Consortium as described below.
Contact Information:
Allison Hutchings
(301) 945-9819
CURRENT FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF
HEALTH:
44. NIDA Research Center of Excellence Grant Program (P50 Clinical Trial
Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-259.html
40
FOA: PAR-19-259 Application Due Date: January 7, 2022
Description: The purpose of this FOA is to provide support for research Centers that (1) conduct drug abuse and
addiction research in any area of NIDA’s mission, (2) have outstanding innovative science, (3) are multidisciplinary,
thematically integrated, synergistic, and (4) serve as national resource(s) to provide educational and outreach activities to
drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research
fields. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be
the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected
to foster the career development and mentoring of new investigators who would be given meaningful roles to play in the
Center projects. A goal of this program is to create NIDA Centers that are national community resources for furthering
drug abuse research by sharing their findings, their data, and their resources as appropriate for researchers to use and build
upon and to advance research in this field.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (all of which are more specifically defined under Section III part 1 of the full text announcement)
Award Information: Budgets for direct costs cannot exceed $10,000,000 for the entire 5 year project period including no
cost extensions, but need to reflect the actual needs of the proposed project. The maximum project period is 5 years.
Contact Information:
Scientific/Research Contact
Kevin Walton, Ph.D.
NIDA
301-435-0762
Meyer D. Glantz, Ph.D.
NIDA
301-443-6504
Roger Little, Ph.D.
NIDA
301-435-1316
Steven Grant, Ph.D.
NIDA
301-443-4877
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Cheryl Nathaniel
NIDA
202-526-5819
45. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses:
Epidemiology and Prevention (R03 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-861.html
FOA: PAR-18-861 Application Due Date: January 7, 2022
41
Description: The purpose of this FOA is to encourage research grant applications that explore whether and how alcohol
and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and
how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: Budgets are limited to $50,000 in direct costs per year. The total project period may not exceed two
years.
Contact Information:
Scientific/Research Contact
Robert Freeman, Ph. D. (for overdose projects)
NIAAA
301-443-8820
Gregory Bloss (for traffic safety projects)
NIAAA
301-443-3865
Marsha Lopez, Ph.D. (for projects intended as NIDA submissions)
NIDA
301-402-1846
Peer Review Contact
Examine your eRA Commons account for review assignment and contact information (information appears two weeks
after the submission due date).
Financial/Grants Management Contact
Judy Fox
NIAAA
301-443-4707
Jennifer Schermerhorn
NIDA
301-827-6704
46. Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial
Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-064.html
FOA: PAR-19-064 Application Due Date: November 8, 2021
Description: This FOA will support pilot, feasibility or exploratory research in 5 priority areas in substance use
epidemiology and health services, including: 1) responses to sudden and severe emerging drug issues (e.g. the ability to
look into a large and sudden spike in opioid or synthetic cannabinoid use/overdoses in a particular community); 2)
responses to emerging marijuana trends and topics related to the shifting policy landscape; 3) responses to unexpected and
time-sensitive prescription drug abuse research opportunities (e.g., new state or local efforts); 4) responses to unexpected
and time-sensitive medical system issues (e.g. opportunities to understand addiction services in the evolving health care
system); and 5) responses to unexpected and time-sensitive criminal or juvenile justice opportunities (e.g. new system
and/or structural level changes) that relate to drug abuse and access and provision of health care service. It should be clear
that the knowledge gained from the proposed study is time-sensitive and that an expedited rapid review and funding are
required in order for the scientific question to be answered (i.e. an imminent policy change will not allow for standard
review and funding timeline).
42
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (all of which are more specifically defined under Section III part 1 of the full text announcement)
Award Information: Direct costs are limited to $275,000 over a two-year project period. No more than $200,000 may be
requested in any single year. The maximum project period is 2 years.
Contact Information:
Scientific/Research Contact
Kelly D. Blake, Sc.D.
NCI
240-281-5934
Marsha Lopez, Ph.D., MHS
NIDA
301-443-6504
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Crystal Wolfrey
NCI
240-276-6277
Jennifer Schermerhorn
NIDA
301-451-2649
47. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to
Stop the Opioid Crisis (R43/R44 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-019.html
FOA: RFA-DA-19-019 Application Due Date: September 8, 2021
Description: This FOA invites eligible United States small business concerns (SBCs) to submit Small Business
Innovation Research (SBIR) grant applications to develop technologies to provide science- and research-based solutions
to the national opioid emergency and offer new hope for individuals, families, and communities affected by this
devastating crisis. United States SBCs that have the research capabilities and technological expertise to contribute to
NIDA R&D mission identified in this FOA are encouraged to submit SBIR grant applications in response to the FOA
topics.
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Award Information: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally
may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the
applicant, Congress will allow awards to exceed these amounts by up to 50% as a hard cap ($225,000 for Phase I and
$1,500,000 for Phase II). However, NIH has received a waiver from SBA, as authorized by statute, to exceed the hard cap
of $225,000 for Phase I or $1,500,000 for Phase II for specific topics. The current list of approved topics can be found
at https://sbir.nih.gov/funding#omni-sbir. Applicants are strongly encouraged to contact NIH program officials prior to
submitting any application in excess of the guidelines and early in the application planning process. In all cases,
applicants should propose a budget that is reasonable and appropriate for completion of the research project. Award
periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a
project duration period that is reasonable and appropriate for completion of the research project.
43
Contact Information:
Scientific/Research Contact
Elena Koustova, Ph.D., MBA
NIDA
301-496-8768
Lili Portilla, MPA
NCATS
301-827-7170
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Amy Connolly
NIDA
301-827-4457
Artisha Eatmon
NCATS
301-594-3028
48. HEAL Initiative: America’s Startups and Small Businesses Build Technologies to
Stop the Opioid Crisis (R41/R42 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-020.html
FOA: RFA-DA-19-020 Application Due Date: September 8, 2021
Description: This FOA invites eligible United States small business concerns (SBCs) to submit Small Business
Technology Transfer (STTR) grant applications to develop technologies to provide science- and research-based solutions
to the national opioid emergency and offer new hope for individuals, families, and communities affected by this
devastating crisis. United States SBCs that have the research capabilities and technological expertise to contribute to
NIDA R&D mission identified in this FOA are encouraged to submit STTR grant applications in response to the FOA
topics.
Eligibility: Only United States small business concerns (SBCs) are eligible to submit applications for this opportunity.
Award Information: According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally
may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the
applicant, Congress will allow awards to exceed these amounts by up to 50% as a hard cap ($225,000 for Phase I and
$1,500,000 for Phase II). However, NIH has received a waiver from SBA, as authorized by statute, to exceed the hard cap
of $225,000 for Phase I or $1,500,000 for Phase II for specific topics. The current list of approved topics can be found
at https://sbir.nih.gov/funding#omni-sbir. Applicants are strongly encouraged to contact NIH program officials prior to
submitting any application in excess of the guidelines and early in the application planning process. In all cases,
applicants should propose a budget that is reasonable and appropriate for completion of the research project.
Award periods normally may not exceed 1 year for Phase I and 2 years for Phase II. Applicants are encouraged to propose
a project duration period that is reasonable and appropriate for completion of the research project.
Contact Information:
Scientific/Research Contact
Elena Koustova, Ph.D., MBA
NIDA
301-496-8768
Lili Portilla, MPA
NCATS
301-827-7170
44
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Amy Connolly
NIDA
301-827-4457
Shannon Oden
NIDA
301-594-3028
49. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses:
Epidemiology and Prevention (R01 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-863.html
FOA: PAR-18-863 Application Due Date: September 7, 2021
Description: The purpose of this FOA is to encourage research grant applications that explore whether and how alcohol
and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and
how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: Budgets are not limited but need to reflect the actual needs of the proposed project. The total
project period may not exceed five years.
Contact Information:
Scientific/Research Contact
Robert Freeman, Ph. D. (for overdose projects)
NIAAA
301-443-8820
Gregory Bloss (for traffic safety projects)
NIAAA
301-443-3865
Marsha Lopez, Ph.D. (for projects intended as NIDA submissions)
NIDA
301-402-1846
Peer Review Contact
Examine your eRA Commons account for review assignment and contact information (information appears two weeks
after the submission due date).
Financial/Grants Management Contact
Judy Fox
NIAAA
301-443-4707
Jennifer Schermerhorn
NIDA
301-827-6704
45
50. Alcohol and Other Drug Interactions: Unintentional Injuries and Overdoses:
Epidemiology and Prevention (R21 - Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-862.html
FOA: PAR-18-862 Application Due Date: September 7, 2021
Description: The purpose of this FOA is to encourage research grant applications that explore whether and how alcohol
and other illicit drugs or illicitly used prescription drugs interact to contribute to unintentional injuries and poisonings and
how to prevent and/or reduce simultaneous use of alcohol or drugs singly or in combination.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: The combined budget for direct costs for the two-year project period may not exceed $275,000. No
more than $200,000 may be requested in any single year. The total project period may not exceed two years.
Contact Information:
Scientific/Research Contact
Robert Freeman, Ph. D. (for overdose projects)
NIAAA
301-443-8820
Gregory Bloss (for traffic safety projects)
NIAAA
301-443-3865
Marsha Lopez, Ph.D. (for projects intended as NIDA submissions)
NIDA
301-402-1846
Peer Review Contact
Ranga Srinivas, Ph.D.
NIAAA
301-451-2067
Financial/Grants Management Contact
Judy Fox
NIAAA
301-443-4707
Jennifer Schermerhorn
NIDA
301-827-6704
51. NIDA Research Education Program for Clinical Researchers and Clinicians (R25
Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/pa-files/PAR-19-258.html
FOA: PAR-19-258 Application Due Date: July 22, 2021
Description: This FOA is intended to support research education activities that enhance the knowledge of substance use
(SU) and substance use disorder (SUD) research. The program is intended for those in clinically focused careers and/or
46
those training for careers as clinicians/health service providers, clinical researchers, or optimally a combination of the two.
This mechanism may not be used to support non-research-related clinical training.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: Budget requests may not exceed $350,000 in direct costs annually. The total project period may not
exceed five years.
Contact Information:
Scientific/Research Contact
Belinda E. Sims, Ph.D.
Division of Epidemiology, Services and Prevention
Research
NIDA
301-402-1533
Guifang Lao, Ph.D.
Division of Therapeutics and Medical Consequences
NIDA
301-443-6173
Yu (Woody) Lin, M.D., Ph.D.
Integrative Neuroscience Branch – Division of
Neuroscience and Behavioral Research
NIDA
301-435-1318
Beth Babecki, M.A.
Coordinator, Training Hub - Division of Neuroscience
and Behavioral Research
NIDA
301-827-5783
Flair Lindsey
Office of Research Training
NIDA
301-827-5783
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Pam Fleming
NIDA
301-443-6710
52. Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol,
and Tobacco Use Disorders (R34 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-774.html
FOA: PAR-18-774 Application Due Date: May 7, 2021
47
Description: This FOA encourages pilot and preliminary research in preparation for larger-scale services research
effectiveness trials. Relevant trials may test a wide range of approaches, including interventions, practices, and policies
designed to optimize access to, and the quality, effectiveness, affordability and utilization of drug, tobacco, or alcohol use
disorder treatments and related services, as well as services for comorbid medical and mental disorder conditions.
Relevant approaches may include both those that are novel, and those that are commonly used in practice but lack an
evidence base. This FOA provides resources for assessing the feasibility, acceptability, and utility of these approaches, in
addition to usual trial preparation activities.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: Direct costs are limited to $450,000 over the 3-year project period, with no more than $225,000 in
direct costs allowed in any single year. The total project period may not exceed three years.
Contact Information:
Scientific/Research Contact
Sarah Q. Duffy, Ph.D.
NIDA
301-451-4998
Lori Ducharme, Ph.D.
NIAAA
301-443-4715
Peer Review Contact
Examine your eRA Commons account for review assignment and contact information (information appears two weeks
after the submission due date).
Financial/Grants Management Contact
Amy Connolly
NIDA
301-827-4457
53. Pilot and Feasibility Studies in Preparation for Drug and Alcohol Abuse
Prevention Trials (R34 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-775.html
FOA: PAR-18-775 Application Due Date: January 7, 2021
Description: This FOA for R34 applications seeks to support: (a) pilot and/or feasibility testing of innovative new,
revised, or adapted prevention intervention approaches to prevent or delay the initiation and onset of drug and alcohol use,
the progression to misuse or problem use or alcohol and other substance use disorder, reduce drinking and driving and
deaths related to impaired driving, prevent suicide attempts (nonfatal and fatal), and the drug- or alcohol-related
acquisition or transmission of HIV infection and viral hepatitis among diverse populations and settings; and, (b) pre-trial
feasibility and acceptability testing for prevention services and systems research. It is expected that research conducted via
this mechanism will consist of studies that are a pre-requisite for preparing and submitting subsequent applications for
larger scale drug or alcohol abuse prevention and/or drug- or alcohol-related HIV prevention intervention studies. This
FOA does not support applications for which the sole focus is development of intervention protocols, manuals, or the
standardization of protocols. Any intervention development work must be imbedded within a pilot/feasibility study. Of
particular interest is prevention research that addresses current public health priorities and priority settings and systems.
48
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, other, and certain foreign institutions (all of which are more specifically defined under Section III part 1 of
the full text announcement)
Award Information: $450,000 in direct costs over three years. No more than $225,000 in direct costs can be used in any
single year. The total project period may not exceed three years.
Contact Information:
Scientific/Research Contact
Jacqueline Lloyd, Ph.D., MSW
NIDA
301-443-8892
Beverly Ruffin, Ph.D.
NIAAA
301-443-0281
Peer Review Contact
Examine your eRA Commons account for review assignment and contact information (information appears two weeks
after the submission due date).
Financial/Grants Management Contact
Edith Davis
NIDA
301-827-6697
Judy Fox
NIAAA
301-443-4704
54. Multi-Site Studies for System-Level Implementation of Substance Use Prevention
and Treatment Services (R01 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-222.html
FOA: PAR-18-222 Application Due Date: November 13, 2020
Description: The purpose of this FOA is to support the development and testing of interventions, models, and/or
frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to
improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and
services.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (all of which are more specifically defined under Section III part 1 of the full text announcement)
Award Information: Budgets are limited to $500,000 in direct costs in any project year, and need to reflect the actual
needs of the proposed project. The total project period may not exceed five years.
Contact Information:
Scientific/Research Contact
Tisha Wiley, Ph.D.
NIDA
301-594-4381
Lori Ducharme, Ph.D.
NIAAA
301-451-8507
Glen D. Morgan, Ph.D.
NCI
240-276-6787
49
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Maryellen Connell
NIDA
301-827-6695
Judy Fox
NIAAA
301-443-4704
Carol Perry
NCI
240-276-6282
55. Multi-Site Pilot & Feasibility Studies for System-Level Implementation of
Substance Use Prevention and Treatment Services (R34 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/pa-files/PAR-18-223.html
FOA: PAR-18-223 Application Due Date: November 13, 2020
Description: The purpose of this FOA is to support the development and testing of interventions, models, and/or
frameworks that examine system-level implementation of evidence-based interventions, guidelines, or principles to
improve the delivery, uptake, quality, and sustainability of substance use prevention and treatment interventions and
services.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (all of which are more specifically defined under Section III part 1 of the full text announcement)
Award Information: The combined budget for direct costs for the three year project period may not exceed $450,000.
No more than $225,000 may be requested in any single year. The total project period may not exceed three years.
Contact Information:
Scientific/Research Contact
Tisha Wiley, Ph.D.
NIDA
301-594-4381
Lori Ducharme, Ph.D.
NIDA
301-451-8507
Peer Review Contact
Gerald McLaughlin, Ph.D.
NIDA
301-827-5819
Financial/Grants Management Contact
Maryellen Connell
NIDA
301-827-6695
50
Judy Fox
NIAAA
301-443-4704
56. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health
Disparities Research in the U.S. (R21 Clinical Trial Optional)
http://grants.nih.gov/grants/guide/pa-files/PAR-18-745.html
FOA: PAR-18-745 Application Due Date: November 13, 2020
Description: The purpose of this Funding Opportunity Announcement (FOA) is to encourage developmental and
exploratory research focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder
(OUD), and understanding and reducing disparities in opioid care in minority health and health disparity populations in
the U.S. This initiative will also seek to identify multi-level intervention strategies at the institutional and systems level
for addressing OUD in these populations.
Eligibility: Small businesses, City or township governments, County governments, Native American tribal organizations
(other than Federally recognized tribal governments), Nonprofits having a 501(c)(3) status with the IRS, other than
institutions of higher education, For profit organizations other than small businesses, Special district governments,
Public and State controlled institutions of higher education, Public housing authorities/Indian housing authorities,
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education, Others (see text
field entitled "Additional Information on Eligibility" for clarification), Native American tribal governments (Federally
recognized), State governments, Private institutions of higher education, and Independent school districts.
Award Information: The combined budget for direct costs for the two year project period may not exceed $275,000. No
more than $200,000 may be requested in any single year. The total project period may not exceed two years.
Contact Information:
Scientific/Research Contact
Andrew Louden, Ph.D. Benyam Hailu, M.D., M.P.H.
NIMHD NIMHD
301-594-9009 301-594-8696
[email protected] [email protected]
Judith A. Arroyo, Ph.D. Victoria Cargill
National Institute on Alcohol Abuse and Alcoholism Office of Research in Women’s Health (ORWH)
301-402-0717 301-435-0971
[email protected] [email protected]
Sarah Duffy Rosemary D. Higgins, MD
NIDA NICHD
301-443-6504 301-435-7909
[email protected] [email protected]
Amelia Karraker, Ph.D.
National Institute on Aging (NIA)
301-496-3131
Peer Review Contact
Weijia Ni, Ph.D
Center for Scientific Review (CSR)
301-594-3292/[email protected]
51
Financial/Grants Management Contact
Priscilla Grant, J.D. Bryan Clark, MBA
NIMHD NICHD
301-594-8412 301-435-6975
[email protected] [email protected]
Amy Connolly Judy Fox
NIDA NIAAA
301-827-4457 301-443-4704
[email protected] [email protected]
57. Addressing the Challenges of the Opioid Epidemic in Minority Health and Health
Disparities Research in the U.S. (R01 Clinical Trial Optional)
http://grants.nih.gov/grants/guide/pa-files/PAR-18-747.html
FOA: PAR-18-747 Application Due Date: November 13, 2020
Description: This funding opportunity announcement (FOA) seeks to support investigative and collaborative research
focused on determining the mechanisms for the variation in the prevalence of Opioid Use Disorder (OUD), and
understanding and reducing disparities in opioid care in minority health and health disparity populations in the U.S. This
initiative will also seek to identify multi-level intervention strategies at the institutional and systems level for addressing
OUD in these populations.
Eligibility: For profit organizations other than small businesses, Nonprofits that do not have a 501(c)(3) status with the
IRS, other than institutions of higher education, Small businesses, Native American tribal governments (Federally
recognized), Private institutions of higher education, County governments, Independent school districts, Nonprofits
having a 501(c)(3) status with the IRS, other than institutions of higher education, Public housing authorities/Indian
housing authorities, City or township governments, Native American tribal organizations (other than Federally recognized
tribal governments), State governments, Others (see text field entitled "Additional Information on Eligibility" for
clarification), Public and State controlled institutions of higher education, and Special district governments
Award Information: Application budgets are not limited but need to reflect the actual needs of the proposed project.
The scope of the proposed project should determine the project period. The maximum project period is 5 years.
Contact Information:
Scientific/Research Contact
Andrew Louden, Ph.D. Benyam Hailu, M.D., M.P.H.
NIMHD NIMHD
301-594-9009 301-594-8696
[email protected] [email protected]
Judith A. Arroyo, Ph.D. Victoria Cargill
National Institute on Alcohol Abuse and Alcoholism Office of Research in Women’s Health (ORWH)
301-402-0717 301-435-0971
[email protected] [email protected]
Sarah Duffy Rosemary D. Higgins, MD
NIDA NICHD
301-443-6504 301-435-7909
52
Amelia Karraker, Ph.D.
National Institute on Aging (NIA)
301-496-3131
Peer Review Contact
Examine your eRA Commons account for review assignment and contact information (information appears two weeks
after the submission due date).
Financial/Grants Management Contact:
Priscilla Grant, J.D. Bryan Clark, MBA
NIMHD NICHD
301-594-8412 301-435-6975
[email protected] [email protected]
Amy Connolly Judy Fox
NIDA NIAAA
301-827-4457 301-443-4704
[email protected] [email protected]
Eva Lawson-Lipchin
National Institute on Aging (NIA)
301-435-2020
PAST FUNDING PROGRAMS THROUGH NATIONAL INSTITUTE OF HEALTH:
58. HEAL Initiative: Antenatal Opioid Exposure Longitudinal Study Consortium
(PL1 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-HD-19-025.html
FOA: RFA-HD-19-025 Application Due Date: March 29, 2019
Description: The purpose of this funding opportunity announcement is to invite applications from consortia composed of
a Data Coordinating Center and 2 or more Clinical Sites to conduct a multi-center prospective cohort study of infants
exposed to opioids in utero compared to unexposed infants. During a 2-year follow-up period, infants will be assessed
with serial measures including neuroimaging, medical, neurodevelopmental, behavioral, and home, social, and family life
assessments.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: The number of awards is contingent upon NIH appropriations and the submission of a sufficient
number of meritorious applications. NIH intends to commit $11 million in multi-year funding in FY 2019 to fund 1 award
to a consortium composed of a Data Coordinating Center (DCC) with 2 cores and 2 or more Clinical Sites. This is part of
the NIH HEAL (Helping to End Addiction Long-term) initiative. Application budgets need to reflect the actual needs of
the proposed project. For the Data Coordinating Center, the base budget is limited to $2 million ($500,000/year) in direct
costs for the entire project period of up to 4 years. Clinical Site applicants may request up to $500,000 ($125,000/year) in
direct costs for the entire project period of up to 4 years.
53
The funds available for capitation will rely, in part, on the number of Clinical Sites included in the Consortium and the
base budgets requested. In general, capitation costs are not subject to facilities and administrative costs.
The scope of the proposed project should determine the project period. The maximum project period is 4 years.
Contact Information:
Scientific/Research Contact
Rosemary D. Higgins, M.D
NICHD
301-435-7909
Peer Review Contact
Sherry Dupere, Ph.D.
NICHD
301-496-1485
Financial/Grants Management Contact
Bryan S. Clark, M.B.A.
NICHD
301-435-6975
59. HEAL Initiative: Integrated Approach to Pain and Opioid Use in Hemodialysis
Patients: The Hemodialysis Opioid Prescription Effort (HOPE) Consortium -
Clinical Centers (U01 Clinical Trial Required)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-18-030.html
FOA: RFA-DK-18-030 Application Due Date: March 27, 2019
Description: The Hemodialysis Opioid Prescription Effort (HOPE) consortium composed of 5 to 7 Clinical Centers
(CCs) and a Scientific and Data Research Center (SDRC) will develop an intervention to simultaneously address the
problem of pain and opioid use in US HD populations by a) initiating multipronged pain treatment tailored individually to
each patient, without opioids, and b) using buprenorphine and other novel agents to reduce dependence on opioids in
affected patients. Analyses will consider comorbid illnesses (such as diabetes and mental health disorders) and social
determinants of health (such as socioeconomic status, social isolation, social support, residential factors, and perception of
racial discrimination) to identify novel risk factors for pain and opioid use in this population. End points will be chronic
opioid prescription rate, prescription drug dose, pain control, patient satisfaction with care, perception of quality of life,
hospitalization rates and mortality. Real time risk factor and outcomes data may be captured using the electronic health
record (EHR), by leveraging and expanding an existing pilot set of more than 200 standardized data elements identified
and prioritized for comprehensive CKD care by the NIDDK CKD eCare Plan Working Group.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: NIDDK intends to commit $4.6 Million in FY 2019 to fund up to 7 awards. Application budgets
are limited to $500,000 direct costs in the first year and should reflect the actual needs of the proposed project. The total
project period may not exceed five years.
54
Contact Information:
Scientific/Research Contact
Paul L Kimmel MD
NIDDK
301-594-1409
Peer Review Contact
Ryan Morris Ph.D.
NIDDK
301-480-1296
Financial/Grants Management Contact
Norma Deguzman
NIDDK
301-480-1810
60. HEAL Initiative: Biofabricated 3D Tissue Models of Nociception, Opioid Use
Disorder and Overdose for Drug Screening (UH2/UH3 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-TR-19-005.html
FOA: RFA-TR-19-005 Application Due Date: February 28, 2019
Description: The purpose of this Funding Opportunity Announcement (FOA) is to support intramural-extramural
collaborations to develop and implement the use of 3D biofabricated tissue models as novel drug screening platforms and
advance pre-clinical discovery and development of non-addictive treatments for nociception, opioid use disorder (OUD)
and/or overdose. In particular, support during the UH2 phase is for the application of 3D biofabrication technologies to
develop novel multicellular tissue constructs for drug screening by using human iPSC-derived cells representing
sensory/pain neurons, brain regions, and other tissues involved in nociception, addiction and/or overdose, including tissue
models of the blood-brain barrier (BBB). Support during the UH3 is for implementation of drug screens using the 3D
tissue models developed during the UH2 phase.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: NCATS intends to fund an estimated of 2-3 awards, corresponding to a total of $1,500,000 for
fiscal year 2019. Future year amounts will depend on annual appropriations. The direct cost for UH2 awards are expected
to be up to $275,000 (exclusive of any contract/consortium F&A) per year. For the UH3 phase, the direct cost amount is
expected to be up to $150,000 per year. The scope of the proposed project should determine the project period. The
proposed project period for the initial development phase (UH2) must not exceed two years. The proposed project period
for the second validation phase (UH3) must not exceed three years.
Contact Information:
Scientific/Research Contact
Dobrila D. Rudnicki, Ph.D.
National Center for Advancing Translational Sciences
301-594-2080
Danilo A. Tagle, Ph.D.
NCATS
301-594-8064
55
Peer Review Contact
Carol Lambert, Ph.D.
NCATS
301-435-0814
Anton Simeonov, Ph.D.
NCATS
301-217-5721
Marc Ferrer, Ph.D.
NCATS
301-217-5722
Michael Oshinsky, Ph.D.
National Institute of Neurological Disorders and Stroke
301-496-9964
Financial/Grants Management Contact Kristin Wegner
NCATS
301-435-0848
Tijuanna Decoster, Ph.D.
NINDS
301-496-9231
61. HEAL Initiative: Tissue Chips to Model Nociception, Addiction, and Overdose
(UG3/UH3 Clinical Trial Not Allowed)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-024.html
FOA: RFA-TR-19-003 Application Due Date: February 28, 2019
Description: This FOA will provide funding for Investigators to create and test devices that can model the mechanisms or
effects of nociception/pain-relevant signaling, addiction, or opioid use disorders (OUDs), using human tissues in in vitro
microphysiological systems (MPS). Tissue chips, or microphysiological systems, are useful and promising in vitro
human-based screening platforms because they closely mimic in vivo human physiology. Tissue chips have been shown
to be capable of modeling normal and diseased physiology that faithfully recapitulates responses to stressors, treatments
and other perturbations.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: NCATS intends to commit approximately $5 million in FY 2019 to fund 4-6 awards. Funding is
contingent on appropriated amounts. Budget requests are limited to $500,000 direct cost per year. The total project period
may not exceed five years.
Contact Information:
Scientific/Research Contact
Lucie Low, Ph.D.
National Center for Advancing Translational Sciences
301-594-7609
Danilo Tagle, Ph.D.
National Center for Advancing Translational Sciences
301-594-8064
Fei Wang, Ph.D.
NIAMS
301-594-5055
Seila Selimovic, Ph.D.
NIBIB
301-451-4577
56
Katerina Tsilou, MD
301-496-6287
Nathan M. Appel, Ph.D.
National Institute on Drug Abuse (NIDA)
301-827-5918
Yolanda F. Vallejo, Ph.D.
NIDCR
301-827-4655
Margaret Sutherland, Ph.D.
National Institute of Neurological Disorders and Stroke
NINDS
301-496-5680
Martha S. Lundberg, Ph.D.
NHLBI
301-435-0513
Peer Review Contact
Carol Lambert, Ph.D.
National Center for Advancing Translational Sciences (NCATS)
301-435-0814
Financial/Grants Management Contact
Ki-Cha Flash
NCATS
301-435-0846
Erik Edgerton
NIAMS
301-594-7760
Katie Ellis
NIBIB
301-451-4791
Bryan Clark
NICHD
301-435-6975
Pam Fleming
NIDA
301-480-1159
Diana Rutberg, MBA
NIDCR
301-594-4798
Tijuana Decoster
NINDS
301-496-9231
Anthony Agresti
NHLBI
301-827-8014
62. HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN)
Clinical Research Centers (UG1 Clinical Trial Optional)
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-025.html
FOA: RFA-DA-19-025 Application Due Date: February 27, 2019
Description: The intersection of justice and community-based health systems is a critical target for addressing the opioid
crisis. The National Institute on Drug Abuse intends to establish the Justice Community Opioid Innovation Network
(JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of
57
investigators examining promising interventions and other approaches that can improve the capacity of the justice system
to effectively respond to the opioid epidemic.
The structure of the network must consist of three highly integrated components - (1) Clinical Research Centers (each
center will propose a study to be executed in at least 5 research performance sites), (2) a single, central Coordination and
Translation Center, and (3) a single, central Methodology and Advanced Analytics Resource Center.
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: NIDA intends to commit $23.5 million in FY 2019 to fund 8-12 awards. Application budgets are
limited to $1,500,000 per year in direct costs. Facilities and administrative costs requested by consortium participants are
not included in the direct cost limitation. The total project period may not exceed five years.
Contact Information:
Scientific/Research Contact
Tisha Wiley, Ph.D.
National Institute on Drug Abuse (NIDA)
301-594-4381
Lori Ducharme, Ph.D.
NIAAA
301-451-8507
Peer Review Contact
Gerald McLaughlin, Ph.D.
National Institute on Drug Abuse (NIDA)
301-827-5819
Financial/Grants Management Contact
Pam Fleming
National Institute on Drug Abuse (NIDA)
301-480-1159
Judy Fox
NIAAA
301-443-4704
63. HEAL Initiative: Justice Community Opioid Innovation Network Coordination
and Translation Center
https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-19-024.html
FOA: RFA-DA-19-024 Application Due Date: February 27, 2019
Description: The intersection of justice and community-based health systems is a critical target for addressing the opioid
crisis. The National Institute on Drug Abuse intends to establish the Justice Community Opioid Innovation Network
(JCOIN) using the cooperative agreement mechanism. The purpose of the network is to establish a national consortium of
investigators examining promising interventions and other approaches that can improve the capacity of the justice system
to effectively respond to the opioid epidemic.
The structure of the network shall consist of three highly integrated components - (1) Clinical Research Centers (each
center will propose a study to be executed at least 5 research performance sites), (2) a single, central Coordination and
Translation Center, and (3) a single, central Advanced Analytics and Methodology Resource Center.
58
Eligibility: Higher education institutions, nonprofits other than institutions of higher education, for-profit organizations,
governments, and others (i.e. public housing authorities, native American tribes, and faith or community-based
organizations).
Award Information: NIDA intends to commit $3.5 million in total costs in FY 2019 to fund 1 award. No more than $2.5
million in direct costs may be requested in any single year. The total project period may not exceed five years.
Contact Information:
Scientific/Research Contact
Tisha Wiley, Ph.D.
National Institute on Drug Abuse (NIDA)
301-594-4381
Lori Ducharme, Ph.D.
NIAAA
301-451-8507
Peer Review Contact
Gerald McLaughlin, Ph.D.
National Institute on Drug Abuse (NIDA)
301-827-5819
Financial/Grants Management Contact
Pam Fleming
National Institute on Drug Abuse (NIDA)
301-480-1159
Judy Fox
NIAAA
301-443-4704
CURRENT FUNDING PROGRAMS THROUGH DOJ’S OFFICE OF JUSTICE
PROGRAMS (OJP):
64. Justice and Mental Health Collaboration Program FY 2019 Competitive Grant
Announcement (BJA)
https://www.bja.gov/funding/JMHCP19.pdf
FOA Number: BJA-2019-15099 Application due: July 15, 2019
Description: The Justice and Mental Health Collaboration Program (JMHCP) supports cross-system collaboration to
improve responses and outcomes for individuals with mental illnesses (MI) or co-occurring mental illness and substance
abuse (CMISA) who come into contact with the justice system. This program supports officer and public safety and
violence reduction through social service and other partnerships that will enhance and increase law enforcement responses
to people with MI and CMISA.
Eligibility: States, units of local government, and federally recognized Indian tribal governments (as determined by the
Secretary of the Interior). BJA will only accept applications that demonstrate that the proposed project will be
administered jointly by an agency with responsibility for criminal or juvenile justice activities and a mental health agency.
Award Information: BJA expects to make up to 57 awards for an estimated total of $23,000,000. See FOA pdf for
specific award amounts and performance periods as they vary based on category applied for.
59
Contact Information:
Response Center
65. Enhancing Community Responses to the Opioid Crisis: Serving Our Youngest
Crime Victims (OVC)
https://www.ovc.gov/grants/pdftxt/Opioids_FY-2019-CompetitiveSolicitation.pdf
FOA Number: OVC-2019-15644 Application due: July 11, 2019
Description: The purpose of this solicitation is to address an urgent gap in crime victim services related to the opioid
epidemic and to expand upon existing or establish new programs to provide services to children and youth2 who are
victimized3 as the result of the opioid crisis. OVC anticipates that this solicitation will support service providers in
expanding their current scope and expertise to ensure that children and youth—the most vulnerable victims impacted by
the opioid crisis—are supported as they heal from the impact of crime and substance abuse.
Eligibility: Limited to nonprofit and for-profit organizations (including tribal nonprofit and for-profit organizations),
faith- and community-based organizations, colleges and universities (including tribal institutions of higher education),
public agencies, state agencies, and federally recognized Indian tribal governments, as determined by the Secretary of the
Interior.
Award Information: Number of awards OVC expects to make Approx. 12 to 24 awards (up to 12 non-tribal awards
and up to 12 tribal awards) Estimated maximum dollar amount for each award Up to $750,000 Total amount anticipated
to be awarded under solicitation Up to $18 million (for tribal and non-tribal jurisdictions, combined).
Contact Information:
Response Center
PAST FUNDING PROGRAMS THROUGH OJP:
66. Improving Reentry for Adults with Co-occurring Substance Abuse and Mental
Illness (BJA)
https://www.bja.gov/funding/CSAMI19.pdf
FOA Number: BJA-2019-15183 Application due: June 25, 2019
Description: The Improving Reentry for Adults with Co-occurring Substance Abuse and Mental Illness Program
improves provision of services to offenders with co-occurring substance abuse and mental illness (CSAMI) when they
leave incarceration to reenter the community, which in turn will help to reduce recidivism and promote public safety.
Specifically, its goal is to improve access to and delivery of standardized screening and assessment, collaborative
comprehensive case management, and pre- and post-release programming for returning inmates that address criminogenic
risk and needs, including treatment and services that address mental illness and substance abuse. The program prioritizes
coordination among corrections, substance abuse, and mental health treatment providers, as well as correctional health,
and parole or probation services, which enables the development of collaborative comprehensive case plans that address
criminogenic risk, substance abuse, and mental health needs. Past grant cohorts have struggled with standardized CSAMI
screening and assessment, case management, fidelity to evidence-based practices for cognitive behavioral therapy and
60
CSAMI, information sharing, and data collection. Within data collection there has been specific issues defining successful
completion, and the development of comprehensive evaluations. Applicants, whether correctional agencies or human
service departments, should consider sustaining the program and system policy changes after the grant period ends.
Eligibility: Limited to states, units of local government, and federally recognized Indian tribes (as determined by the
Secretary of the Interior)
Award Information: BJA expects to make up to 10 awards of up to $1,000,000 each, with an estimated total amount
awarded of up to $10,000,000. BJA expects to make awards for a 48-month period of performance, to begin on October 1,
2019
Contact Information:
Response Center
67. Second Chance Act Comprehensive Community-based Adult Reentry Program
(BJA)
https://www.bja.gov/funding/SCAComRe19.pdf
FOA Number: BJA-2019-15223 Application due: June 11, 2019
Description: Under this solicitation, BJA is seeking applications to implement or expand on reentry programs that
demonstrate strong partnerships with corrections, parole, probation, law enforcement, and other reentry service providers.
These partnerships should develop comprehensive case management plans that directly address criminogenic risk and
needs, as determined by validated criminogenic risk assessments, and includes delivery or facilitation of services in a
manner consistent with the learning styles and abilities of the participants. This includes ensuring cognitive behavioral
programming is in place pre-release, whether by the lead applicant or a partnering agency.
Participants are expected to be screened, assessed, and identified for program participation pre-release. During the post-
release phase of the reentry program, participants will receive case management services and be connected to evidence-
based programming designed to assist in the transition from prison or jail to the community so that it is safe and
successful. Where feasible, case management services and evidence-based programming should begin during the pre-
release phase.
Eligibility: Eligible applicants are limited to nonprofit organizations (including tribal nonprofit organizations) with a
documented history of providing comprehensive, evidence-based reentry services and federally recognized Indian tribes.
All recipients and subrecipients (including any for-profit organization) must forgo any profit or management fee.
1. Community-based Adult Reentry.
Target Population: The proposed program must commit to serving a minimum of 150 people that
meet the target population requirements of this grant. (See page 8 for information about target
population.)
Award Amount: Awardees will receive up to $1,000,000 each
2. Community-based Adult Reentry with Small or Rural Organizations.
Applicants must demonstrate an annual operating budget of $1,000,000 or less and not be a chapter or
affiliate of a national organization, as defined by having a licensing or other agreement where the
national entity provides financial and/or operational support. Special consideration will be given to
those organizations operating in and serving a rural area of the country.
Target Population: The proposed program must commit to serving a minimum of 75 people that meet
the target population requirements of this grant.
61
Award Amount: Awardees will receive up to $500,000 each.
Award Information: BJA expects to make 9 awards of up to $1,000,000 each for category 1 and 5 awards of up to
$500,000 for category 2, with an estimated total amount awarded of up to $11,500,000. BJA expects to make all awards
for a 48-month project period, beginning on October 1, 2019.
Contact Information:
Response Center
68. Improving Justice and Mental Health Collaboration: Training and Technical
Assistance to Grantees and the Field (BJA)
https://www.bja.gov/funding/JMHCPTTA19.pdf
FOA Number: BJA-2019-15123 Application due: June 11, 2019
Description: The primary goal of JMHCP is to facilitate cross-system collaboration among the criminal justice, mental
health, and substance abuse treatment systems to increase access to mental health and other treatment services for
individuals with mental illnesses (MI) or co-occurring mental illness or substance abuse (CMISA). The primary goal of
CBP is to provide comprehensive resources and services to unfunded JMHCP applicants (“customers”) and the field in
general.
1. Justice and Mental Health Collaboration Program Training and Technical Assistance. Objectives:
• Provide comprehensive, responsive, individualized TTA to JMHCP Category 1, 2, and 3 grantees to
meet their objectives, deliverables, and activities.
• Provide TTA to assist JMHCP Category 1 Collaborative County Approaches to Reducing the
Prevalence of Individuals with Serious Mental Illness in Jails grantees to increase and maintain jail
capacity for violent offenders, and develop system wide coordinated approaches to safely reduce the
prevalence of low risk individuals with MI and CMISA in local jails.
• Provide targeted TTA to assist JMHCP Category 2 Strategic Planning for Police and Mental Health
Collaboration grantees to free up law enforcement time to focus on responding to violent crime and to
improve officer and citizen safety during calls for service involving people with MI and CMISA.
• Provide TTA to assist JMHCP Category 3 Implementation and Expansion grantees to increase public
safety and reduce recidivism among high risk people with MI and CMISA.
2. Justice and Mental Health State-based Capacity Building Program. Objectives:
• To develop and provide information and TTA to the field and to support cross-organizational
coordination.
• To increase coordination, tools and resources that build state and local capacity to improve system
responses to, and outcomes for, people with mental illnesses in the justice system.
Eligibility: Eligible applicants are nonprofit organizations (including tribal organizations) and for-profit (commercial and
tribal) organizations, faith-based and community organizations, and institutions of higher education (including tribal
institutions of higher education).
Award Information: BJA expects to make up to two awards with an estimated total amount awarded of up to
$4,340,000. BJA will make two awards, one award in Category 1 and one award in Category 2, each with a twelve month
period of performance. Specific award amounts for each category are identified below.
1. Up to $2,480,000. Project period: 12 months.
2. Up to $1,860,000. Project period: 12 months.
Contact Information:
62
Response Center
69. Comprehensive Opioid Abuse Site-based Program (BJA)
https://www.bja.gov/funding/COAP19.pdf
FOA Number: BJA-2019-15111 Application due: June 5, 2019
Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance
(BJA) is seeking applications to plan and implement comprehensive programs in response to the growing opioid
epidemic. This program furthers the Department’s mission by providing resources to support state, local, tribal, and
territorial efforts to reduce violent crime and drug abuse and enhance public safety, while supporting victims.
Eligibility: Eligible applicants are those that meet the following criteria for the three categories:
1. Locally Driven Responses to the Opioid Epidemic – Applicants are limited to units of local government and
federally recognized Indian tribal governments (as determined by the Secretary of the Interior). Jurisdictions
without a county- or local government-based addiction service system may designate the State Administering
Agency (SAA) to serve as the primary applicant and subgrant funds to providers at the county level.
Applicants should ensure they apply under the appropriate subcategory based on the population of the
proposed project area.
a. An urban area or large county with a population greater than 500,000.
b. A suburban area or medium-size county with a population between 100,000 and 500,000.
Subcategory
c. A rural area or small county with a population of fewer than 100,000 or a federally recognized Indian
tribe.
2. Statewide Implementation, Enhancement, and Evaluation Projects – Applicants are limited to the SAA
responsible for directing criminal justice planning or the State Alcohol and Substance Abuse Agency.
3. Harold Rogers Prescription Drug Monitoring Program (PDMP) Implementation and Enhancement Projects –
Applicants are limited to state governments and territories that have a pending or enacted enabling statute or
regulation requiring the submission of controlled substance prescription data to an authorized state agency.
Award Information: BJA expects to make up to 80 awards for varying amounts and performance periods, depending on
the category or subcategory under which the application is awarded (see below). BJA anticipates that over half of these
awards will be funded by the CARA appropriation and the remaining awards will be funded under the Harold Rogers
Prescription Drug Monitoring Program. All performance periods should begin on or after October 1, 2019.
All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that
may be imposed by law.
1. Locally Driven Responses to the Opioid Epidemic. Project period: 36 months. The maximum award amount
available is based on the population of the proposed community to be served as described below.
a. The maximum award available for Category 1a is $1,200,000 for the entire grant period. Subcategory
b. The maximum award available for Category 1b is $900,000 for the entire grant period. Subcategory
c. The maximum award available for Category 1c is $600,000 for the entire grant period
2. Statewide Implementation, Enhancement and Evaluation Projects. Project period: 36 months. Applicants may
apply for Subcategory 2a (projects to be implemented in 3 to 5 sites may request up to $3,000,000; projects to be
implemented in 6 or more sites may request up to $5,000,000) for up to a 36-month period; Subcategory 2b
(projects to be implemented in 3 or more sites may request up to $1,500,000) for up to a 36-month period; or
Subcategory 2c (up to $6,500,000) for up to a 36-month period.
63
3. Applicants under Category 3 may request a project period of 36 months and an award amount no greater than
$2,000,000
Categories 1 and 2: BJA expects that any award under this solicitation in these categories will be made in the form of a
cooperative agreement. Priority consideration will be given to applicants that:
• Demonstrate the state, or regions within the state, have been disproportionately impacted by the abuse of illicit
opioids and prescription drugs as evidenced, in part, by high rates of primary treatment admissions; high rates of
overdose deaths from heroin and other opioids; and/or a lack of accessibility to treatment providers and facilities and
to emergency medical services.
• Include a research partner that will assist in the identification of the problem, design of the solution, and evaluation
of the proposed initiative.
• Incorporate the use of Overdose Detection Mapping Application Program.
Category 3: BJA expects that any award under this solicitation will be made in the form of a grant. Priority consideration
will be given to applicants that have pending or enacted state legislation that:
• Requires licensed prescribers to register with the PDMP.
• Requires prescribers to query the PDMP before prescribing drugs in Schedules II, III, and IV.
• Allows the PDMP to proactively analyze their data.
• Requires interstate data sharing of PDMP data.
• Allows law enforcement access to the PDMP based on an open investigation.
• Allows unsolicited reports to be sent to regulatory/licensing boards and law enforcement.
Contact Information:
Response Center
800-851-3420
70. Juvenile Drug Treatment Court Program (OJJDP)
https://www.ojjdp.gov/grants/solicitations/FY2019/JDTC.pdf
FOA Number: OJJDP-2019-15032 Application due: May 30, 2019
Description: The Juvenile Drug Treatment Court Program builds the capacity of states, state and local courts, units of
local government, and federally recognized tribal governments to enhance existing drug courts or implement new juvenile
drug treatment courts (JDTCs) for individuals with substance abuse problems or co-occurring mental health disorders,
including histories of trauma. OJJDP expects successful applicants to develop and implement a sustainability plan during
the grant period to continue operation of the drug court when the grant ends.
1. Juvenile Drug Treatment Court Planning: This program will support jurisdictions that have identified a need
to establish a JDTC. Funding under this program will support a 24-month planning process that will educate
the JDTC team about the basic components of a JDTC and develop a program that integrates court and
treatment functions.
2. Juvenile Drug Treatment Court Enhancement: The goal of this category is to enhance the capacity of JDTCs
and ultimately improve the outcome for the youth involved in the JDTC. Applicants may consider
enhancements on one or more of the following key components of a JDTC, but are not limited to these.
JDTCs should propose enhancements according to their greatest areas of need for improvement.
Eligibility: Government Entities. Eligible App Subcategories: Courts, Local, State, U.S. Territories
Award Information: OJJDP expects to make 10 awards for a total of $3,250,000.
1. Up to 5 awards of $250,000 each, period of performance is 2 years.
64
2. Up to 5 awards of $400,000 each, period of performance is 3 years.
Contact Information:
Response Center
800-851-3420
71. Family Drug Court Program (OJJDP)
https://www.ojjdp.gov/grants/solicitations/FY2019/FDCP.pdf
FOA Number: OJJDP-2019-15026 Application due: May 29, 2019
Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Office of Juvenile Justice and
Delinquency Prevention (OJJDP) is seeking applications for funding under the fiscal year (FY) 2019 Family Drug Courts
Program. This program furthers the Department’s mission by supporting states and communities as they develop and
implement effective and coordinated substance abuse intervention programs.
This solicitation incorporates the OJP Grant Application Resource Guide by reference. The OJP Grant Application
Resource Guide provides guidance to applicants on how to prepare and submit applications for funding to OJP. If this
solicitation expressly modifies any provision in the OJP Grant Application Resource Guide, the applicant is to follow the
guidelines in this solicitation as to that provision. There are three categories
1. To enhance and/or expand existing family drug courts to provide substance-abusing parents with treatment
and accountability by offering access to recovery services that will ultimately protect children; reunite
families, when safe to do so; and, expedite permanency.
2. Serving Veterans Through Family Drug Courts: It is estimated that between 30-35% of veterans are affected
by overlapping trauma and substance abuse disorders. Secondary trauma affecting veteran families has been
documented, along with higher frequency of family stress and violence.10 Substance abuse disorders, as well
as co-occurring mental health disorders such as post-traumatic stress, brain injuries, and other consequences
of military service and/or deployment, may result in some of these families being referred to child protective
services or family violence caseloads in response to incidents within the family. Therefore, identifying and
addressing parental distress are critical to preventing and intervening in child maltreatment in veteran
families. A collaborative approach among child and
3. Establishing New Family Drug Courts: The goal of programs funded under Category 3 is to implement new
family drug courts to provide substance-abusing parents with treatment and accountability by offering access
to recovery services that will ultimately protect children; reunite families, when safe to do so; and expedite
permanency. Priority will be given to applicants that include a plan to develop and implement a specialized
track of services for military veteran parents in their programs.
Eligibility: Eligible applicants are limited to states, territories, State courts, local courts, units of local government, and
federally recognized Indian tribal governments (as determined by the Secretary of the Interior) acting on behalf of a single
jurisdiction drug court. Faith and community-based organizations, nonprofit organizations and for-profit organizations
(including tribal nonprofit and for-profit organizations), and institutions of higher education
This solicitation is composed of three grant categories. Applicants must clearly designate the category for which they are
applying. Category 1: Enhancing Family Drug Courts and Category 2: Serving Veterans Through Family Drug Courts are
available to jurisdictions with a fully operational family drug court. Courts applying for funding under category 1 or 2
must be fully operational for at least 1 year, as funding is intended to enhance services of existing family drug courts.
Category 3: Establishing New Family Drug Courts grants are available to jurisdictions that are ready to implement a new
family drug court. These grants are for jurisdictions where either no family drug court currently exists or a family drug
65
court has been operational for less than 1 year. Jurisdictions may already have other types of drug or treatment courts
(such as adult drug or mental health courts).
All Categories. All recipients and subrecipients (including any for-profit organization) must forgo any profit or
management fee.
OJJDP will consider applications under which two or more entities would carry out the federal award; however, only one
entity may be the applicant. Any others must be proposed as subrecipients (subgrantees). The applicant must be the entity
that would have primary responsibility for carrying out the award, including administering the funding and managing the
entire program. Under this solicitation, only one application by any particular applicant entity will be considered. An
entity may, however, be proposed as a subrecipient (subgrantee) in more than one application. For additional information
on subawards, see the OJP Grant Application Resource Guide.
Award Information: OJJDP expects to make a maximum of 14 awards. Total amount anticipated to be awarded under
solicitation: $9,000,000 million for a period of performance of 3 years.
1. OJJDP expects to make eight awards of up to $750,000 each.
2. OJJDP expects to make three awards of up to $350,000 each.
3. OJJDP expects to make three awards of up to $650,000 each.
Contact Information:
Response Center
800-851-3420
72. Office Anti-Heroin Task Force (AHTF) Program Application Guide (COPS)
https://cops.usdoj.gov/pdf/2019AwardDocs/ahtf/FY19_AHTF_App_Guide.pdf
FOA Number: : COPS-AHTF-APPLICATION-2019 Application due: May 28, 2019
Description: AHTF funds awarded in this program shall be used for investigative purposes to locate or investigate illicit
activities, including activities related to the distribution of heroin, fentanyl, or carfentanil or the unlawful distribution of
prescription opioids. AHTF will be open to state law enforcement agencies with multijurisdictional reach and an
interdisciplinary team (e.g. task force) structures. These state law enforcement agencies must have primary law
enforcement authority over heroin and other opioids seizures.
Eligibility: Open to state law enforcement agencies in states with high per capita rates of primary treatment admissions,
for the purpose of locating or investigating illicit activities, through statewide collaboration, relating to the distribution of
heroin, fentanyl, or carfentanil or the unlawful distribution of prescription opioids. These state law enforcement agencies
must have primary authority over state seizures of heroin and other opioids.
Award Information: AHTF provides funding for 24 months directly to state law enforcement agencies with high rates of
primary treatment admissions for heroin and other opioids. The COPS Office anticipates making approximately 10 2019
AHTF awards for a total of approximately $32,000,000. Funding requests under this program will be capped at
$3,000,000 per award.
Contact Information:
Response Center
800-421-6770
66
73. Tribal Justice CTAS Training and Technical Assistance Solicitation (BJA)
https://www.bja.gov/funding/TribalJusticeTTA19.pdf
FOA Number: BJA-2019-15929 Application due: May 14, 2019
Description: The TTA will provide tribal jurisdictions with assistance to: (1) develop strategies to address crimes relating
to substance abuse and other controlled substances; and (2) implement and enhance tribal justice systems including tribal
law enforcement, courts, prosecution, and pretrial; (3) conduct comprehensive justice system-wide strategic planning and
develop written justice systemwide strategic plans; (4) address violent crime in tribal communities; (5) address the tribal
justice needs of Alaska Native Villages; and (6) develop and foster intergovernmental collaboration among tribal-federal-
state-local governments in order to improve public safety and victims’ services. The main focus of the TTA will be with
tribes who receive funding under CTAS Purpose Areas 2 (Strategic Planning), 3 (Tribal Justice Systems), and 10 (Violent
Crime).
Eligibility: For-profit organizations, nonprofit organizations (including tribal nonprofit or for-profit organizations), faith-
based and community organizations, institutions of higher education (including tribal institutions of higher education),
and consortiums (including tribal consortiums) with demonstrated national-scope and onsite experience working with
American Indian and Alaska Native tribes.
Award Information: BJA expects to make up to 7 awards of up to $300,000 - $800,000 each (see pages 11-19 for
details) with an estimated total amount awarded of up to $5,025,000 for an 18 - 24-month project period, beginning on
October 1, 2019.
Contact Information:
Response Center
800-851-3420
74. Opioid Affected Youth Initiative (OJJDP)
https://www.ojjdp.gov/grants/solicitations/FY2019/Opioid.pdf
FOA Number: OJJDP-2019-15035 Application due: May 7, 2019
Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Office of Juvenile Justice and
Delinquency Prevention is seeking applications for funding under the fiscal year (FY) 2019 Opioid Affected Youth
Initiative. This Initiative supports states, local communities, and tribal jurisdictions in their efforts to develop and
implement effective programs for children, youth, and at-risk juveniles and their families who have been impacted by the
opioid crisis and drug addiction.
This solicitation incorporates the OJP Grant Application Resource Guide by reference. The OJP Grant Application
Resource Guide provides guidance to applicants on how to prepare and submit applications for funding to OJP. If this
solicitation expressly modifies any provision in the OJP Grant Application Resource Guide, the applicant is to follow the
guidelines in this solicitation as to that provision.
Eligibility: Eligible applicants are limited to states (including territories), units of local government, and federally
recognized tribal governments as determined by the Secretary of the Interior.
All recipients and subrecipients (including any for-profit organization) must forgo any profit or management fee. OJJDP
will consider applications under which two or more entities would carry out the federal award; however, only one entity
67
may be the applicant. Any others must be proposed as subrecipients (subgrantees). The applicant must be the entity that
would have primary responsibility for carrying out the award, including administering the funding and managing the
entire program.
Under this solicitation, only one application by any particular applicant entity will be considered. An entity may, however,
be proposed as a subrecipient (subgrantee) in more than one application. For additional information on subawards, see the
OJP Grant Application Resource 2 OJJDP-2019-15035 Guide.
Award Information: OJJDP expects to make up to 7 awards of up to $1,000,000 each for a total of $7,000,000. The
period of performance starting October 1, 2019 and continuing for 3 years.
All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that
may be imposed by law.
Contact Information:
Response Center
800-851-3420
75. Drug Court Training and Technical Assistance Program (OJJDP)
FOA Number: OJJDP-2019-15023 Application due: May 6, 2019
Description: This program will fund training and technical assistance (TTA) to states, state and local courts, units of local
government, and tribal governments that will build their capacity to develop, maintain, and enhance drug courts for
juveniles and parents/guardians with substance abuse problems or co-occurring mental health disorders, specifically those
related to opioid abuse. This solicitation has two categories—Category 1: Juvenile Drug Treatment Courts Training and
Technical Assistance Program and Category 2: Family Drug Courts Training and Technical Assistance Program.
1. Category 1: Juvenile Drug Treatment Courts TTA Program The goal of the Juvenile Drug Treatment
Courts TTA Program: is to build the capacity and effectiveness of juvenile drug treatment courts. The
successful applicant should have substantial experience in assessing TTA needs, effectively communicating
and collaborating with drug courts, providing peer-to-peer training, providing individualized technical
assistance, and conducting post-training follow-up and evaluations. Training and technical assistance should
be targeted to all OJJDP-funded juvenile drug treatment courts and reach as many juvenile drug treatment
courts as possible.
2. Category 2: Family Drug Courts TTA Program The goal of the Family Drug Courts TTA Program: is
to help family drug court practitioners develop, maintain, and enhance family drug courts. The successful
applicant should have substantial experience in assessing training needs, effectively communicating and
collaborating with drug courts, providing peer-to-peer training, and conducting post-training follow-up and
evaluations. It is expected that the successful applicant will develop a TTA strategy and prioritization
approach that includes both OJJDP-funded family drug courts and other family drug courts with identified
needs. 9
Eligibility: Eligible applicants are limited to nonprofit organizations1 and for-profit organizations (including tribal
nonprofit and for-profit organizations) and institutions of higher education (including tribal institutions of higher
education). All recipients and subrecipients (including any for-profit organization) must forgo any profit or management
fee.
OJJDP welcomes applications under which two or more entities would carry out the federal award; however, only one
entity may be the applicant. Any others must be proposed as subrecipients (subgrantees).2 The applicant must be the
68
entity that would have primary responsibility for carrying out the award, including administering the funding and
managing the entire program. Under this solicitation, only one application by any particular applicant entity will be
considered. An entity may, however, be proposed as a subrecipient (subgrantee) in more than one application.
Award Information: OJJDP expects to make up to two awards with an estimated total amount awarded of up to
$8,000,000. OJJDP expects to make awards for a 36-month period of performance, to begin on October 1, 2019.
1. Under Category 1 (Juvenile Drug Treatment Courts TTA), OJJDP expects to make one award of up to
$3,500,000.
2. Under Category 2 (Family Drug Courts TTA), OJJDP expects to make one award of up to $4,500,000.
OJJDP-2019-15023 13 All awards are subject to the availability of appropriated funds and to any
modifications or additional requirements that may be imposed by law.
Contact Information:
Response Center
800-851-3420
76. Research and Evaluation on Drugs and Crime (NIJ)
https://nij.gov/funding/Documents/solicitations/NIJ-2019-15444.pdf
FOA Number: BJA-2019-15269 Application due: May 6, 2019
Description: This program furthers DOJ’s mission to combat the Nation's opioid epidemic, support prosecutors in their
efforts, and reduce violent and other drug-related crime through research that promotes effective law enforcement, court,
and corrections responses to illegal drug markets (including diversion of legal drugs). The research focus of this
solicitation is criminal investigation, prosecution, drug intelligence, and community surveillance relevant to narcotics law
enforcement, forensic science, and/or medicolegal death investigation. DOJ has identified the FY 2019 solicitation drug
priorities as: 1) fentanyl and its illicit analogues; 2) methamphetamine; and 3) illegal marijuana markets.
Eligibility: In general, NIJ is authorized to make grants to, or enter into contracts or cooperative agreements with, States
(including territories), units of local government, federally recognized Indian tribal governments that perform law
enforcement functions (as determined by the Secretary of the Interior), nonprofit and for-profit organizations (including
tribal nonprofit and for-profit organizations), institutions of higher education (including tribal institutions of higher
education), and certain qualified individuals.
NIJ welcomes applications under which two or more entities would carry out the federal award; however, only one entity
may be the applicant. Any others must be proposed as subrecipients (subgrantees) . The applicant must be the entity that
would have primary responsibility for carrying out the award, including administering funding, managing the entire
project, and monitoring and appropriately managing any subawards (“subgrants”).
Under this solicitation, any particular applicant entity may submit more than one application, as long as each application
proposes a different project in response to the solicitation. Also, an entity may be proposed as a subrecipient (subgrantee)
in more than one application.
NIJ may elect to fund applications submitted under this FY 2019 solicitation in future fiscal years, dependent on, among
other considerations, the merit of the applications and on the availability of appropriations.
Award Information: NIJ anticipates at least $3 million will be available to fund five or more grants across the three drug
priorities. Awards will normally not exceed a three-year period of performance, and applications proposing shorter
timelines are preferred.
69
Contact Information:
Response Center
800-851-3420
77. Residential Substance Abuse Treatment (RSAT) for State Prisoners Program
https://www.bja.gov/funding/rsat19.pdf
FOA Number: BJA-2019-15269 Application due: April 30, 2019
Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Assistance
(BJA) is seeking applications for funding under the Residential Substance Abuse Treatment for State Prisoners Program.
This program furthers the Department’s mission by assisting state, local, and tribal efforts to break the cycle of drug
addiction and violence by reducing the demand for, use, and trafficking of illegal drugs.
This solicitation incorporates the OJP Grant Application Resource Guide by reference. It provides guidance to applicants
on how to prepare and submit applications for funding to OJP. If this solicitation expressly modifies any provision in the
OJP Grant Application Resource Guide, the applicant is to follow the guidelines in this solicitation as to that provision.
This solicitation expressly modifies the OJP Grant Application Resource Guide by not incorporating the “Limitation on
Use of Award Funds for Employee Compensation; Waiver” provisions in the “Financial Information” section of the OJP
Grant Application Resource Guide.
Eligibility: Eligible applicants are limited to states. For purposes of this solicitation, states are defined as all U.S. states,
the District of Columbia, the Commonwealth of Puerto Rico, the U.S. Virgin Islands, American Samoa, Guam, and the
Northern Mariana Islands. By statute (34 U.S.C § 10421), BJA must award RSAT grants to the state office (see
www.ojp.usdoj.gov/saa/index.htm for Administering Agencies list) designated to administer the Byrne Justice Assistance
Grant Program. The state office may award subgrants1 to state agencies and units of local government, including
federally-recognized Indian tribal governments that perform law enforcement functions (as determined by the Secretary of
the Interior).
In order to be eligible to receive an award under this solicitation, the application must demonstrate that a minimum of 25
percent of the total costs of each project under an award will be funded with non-federal funds. The federal share of an
RSAT award may not exceed 75 percent of the total costs of the projects described in the application. 34 U.S.C. 10424.
Award Information: Each participating state is allocated a base award of 0.4 percent of the total funds available for
RSAT. BJA will allocate a portion of the total remaining funds to each participating state in the same percentage that the
state’s prison population represents relative to the total prison population of all states. BJA estimates that it will make up
to 56 awards for an estimated total of $12,000,000 for a 48-month period of performance, beginning on October 1, 2019.
Contact Information:
Response Center
800-518-4726
78. Mentoring Opportunities for Youth Initiative: Category 1-5: (OJJDP)
https://www.ojjdp.gov/grants/solicitations/FY2019/MentOpps.pdf
70
Grants.gov Number: OJJDP-2019-15004 Application due: April 22, 2019
Description: The U.S. Department of Justice (DOJ), Office of Justice Programs (OJP), Office of Juvenile Justice and
Delinquency Prevention (OJJDP) is seeking applications for funding under the fiscal year (FY) 2019 Mentoring
Opportunities for Youth Initiative. This program furthers the Department’s mission by supporting mentoring programs to
reduce juvenile delinquency, drug abuse (especially opioid abuse), victimization, and problem and high-risk behaviors
such as truancy.
Eligibility: All recipients and subrecipients (including any for-profit organization) must forgo any profit or management
fee. OJJDP may elect to fund applications submitted under this FY 2019 solicitation in future fiscal years, dependent on,
among others considerations, the merit of the applications and the availability of appropriations.
1. National Mentoring Programs.
a. Eligible applicants are limited to national organizations, defined as organizations that have active chapters
or subawardees in at least 45 states. Applicants must include a list of active chapters or subawardees and
the states where they are located as an attachment to their application. For the purposes of this
solicitation, 2 or more independent organizations that form a collaborative to meet the 45-state
requirement do not satisfy OJJDP’s definition of a national organization. The organization’s national
headquarters must submit the application. OJJDP encourages applicants to minimize their administrative
costs in an effort to subaward at least 90 percent of this award to active chapters or subrecipients, located
in at least 38 states, while at the same time allowing for effective subrecipient oversight.
2. Multistate Mentoring Programs.
a. Eligible applicants are limited to multistate organizations, defined as organizations that have operated an
established mentoring program for at least 3 years and have active chapters or subawardees in at least 5
states but fewer than 45 states. Applicants must include a list of active chapters or subawardees and the
states where they are located as an attachment to their application. For the purposes of this solicitation,
two or more independent organizations that form a collaborative to meet the five-state requirement do not
satisfy OJJDP’s definition of a multistate organization. The organization’s headquarters must submit the
application.
3. Mentoring Programs for Youth Involved in the Juvenile Justice System.
a. Eligible applicants are limited to private organizations (nonprofit organizations2 and for-profit
organizations, including tribal nonprofit and for-profit organizations, and faith-based organizations). Joint
applications from two or more eligible applicants are welcome; however, one applicant must be clearly
indicated as the primary applicant (for correspondence, award, and management purposes) and the others
indicated as coapplicants. To be eligible in Category 3, applicants must at the time of application: • Have
operated an established mentoring program for at least 1 year. • Have a demonstrated partnership (via a
memorandum of understanding) with a public agency legally responsible for handling juvenile crime and
delinquency in a state, tribe, city, or county (hereafter referred to as juvenile justice agency).
4. Mentoring Strategies for Youth Impacted by Opioids
a. Eligible applicants are limited to private organizations (nonprofit organizations and for-profit
organizations, including tribal nonprofit and for-profit organizations, and faith-based organizations). Joint
applications from two or more eligible applicants are welcome; however, one applicant must be clearly
indicated as the primary applicant (for correspondence, award, and management purposes) and the others
indicated as coapplicants. To be eligible in Category 4, applicants must at the time of application: • Have
operated an established mentoring program for at least 1 year. • Have a demonstrated partnership (via a
memorandum of understanding) with a public or private substance abuse treatment agency.
5. Statewide and Regional Mentoring Initiative for Youth Impacted by Opioids
a. Eligible applicants are limited to national organizations (as defined in Category 1), states (including
territories), and federally recognized tribal governments as determined by the Secretary of the Interior.
Eligible applicants must provide mentoring services to youth who are 17 years old or younger at the time
of admission to the program. An organization that applies for funding in Category 1 may also be eligible
to apply for Category 5, but is ineligible to apply for funds in Categories 2, 3, and 4. An organization that
applies for funding in Category 2 may also apply to receive funds in Categories 3 and 4.
71
Award Information: When making final award decisions, OJJDP will consider geographic coverage; the provision of
services to specific populations, including rural and tribal communities; and the peer review results. OJJDP expects to
award grant funds under this solicitation no later than September 30, 2019.
All awards are subject to the availability of appropriated funds and to any modifications or additional requirements that
may be imposed by law.
1. An application may be for a period of performance of as long as 3 years. The requested award amount should
cover the entire proposed period of performance and be based on the allowable costs associated with the
program, including but not limited to the costs of planning and implementing the proposed program. OJJDP
encourages applicants to minimize their administrative costs in an effort to subaward at least 90 percent of
this award to active chapters or subrecipients, located in at least 38 states, while at the same time allowing for
effective subrecipient oversight. Based on the availability of funding, OJJDP may request that an applicant
selected for funding reduce their proposed budget. OJJDP plans to make up to five awards in this category.
2. An application may be for a period of performance of as long as 3 years. Applicants that meet the minimum
requirement of having active chapters or subawardees in at least five states may request as much as $2
million, and those applicants that demonstrate the broadest reach (as detailed above) may request as much as
$4 million. See the priority considerations for Category 2 listed on pages 7–8. The requested award amount
should cover the entire proposed period of performance and be based on the cost of implementing the
proposed program. Based on the availability of funding, OJJDP may request that an applicant selected for
funding reduce their proposed budget. OJJDP plans to make up to twelve awards in this category.
3. An applicant may request as much as $500,000 for a period of performance of as long as 3 years. The
requested award amount should cover the entire proposed period of performance and be based on the cost of
implementing the proposed program. Based on the availability of funding, OJJDP may request that an
applicant selected for funding reduce their proposed budget. OJJDP plans to make up to nine awards in this
category.
4. An applicant may request as much as $500,000 for a period of performance of as long as 3 years. The
requested award amount should cover the entire proposed period of performance and be based on the cost of
implementing the proposed program. Based on the availability of funding, OJJDP may request that an
applicant selected for funding reduce their proposed budget. OJJDP plans to make up to nine awards in this
category.
5. An applicant may request as much as $1,250,000 for a period of performance of as long as 3 years. The
requested award amount should cover the entire proposed period of performance and be based on the cost of
implementing the proposed program. Based on the availability of funding, OJJDP may request that an
applicant selected for funding reduce their proposed budget. OJJDP plans to make up to six awards in this
category.
Contact Information:
Response Center
800-851-3420
79. Innovative Prosecution Solutions for Combating Violent Crime (BJA)
https://www.bja.gov/funding/IPS19.pdf
FOA Number: BJA-2019-15225 Application due: April 16, 2019
Description: The purpose of this program is to provide state, local, and tribal prosecutors with information, resources, and
training and technical assistance (TTA) to develop effective strategies and programs to address and prosecute individuals
who commit violent crime. Prosecutors are leaders within the criminal justice system and possess an enormous
72
responsibility within the criminal justice system. Accordingly, they are well-positioned to bring the police, community,
and local agencies together to combat violent crime in their jurisdictions.
Eligibility: Eligible applicants are limited to state and local prosecutorial agencies, federally recognized Indian tribal
governments that perform prosecution functions (as determined by the Secretary of the Interior), or tribal consortia
consisting of two or more federally recognized Indian tribes (including tribal consortia operated as nonprofit
organizations) acting as a fiscal agent for one or more prosecutor agencies.
Award Information: BJA estimates that it will make up to six awards of up to $360,000 each for an estimated total of
$2,160,000 for a 24-month period of performance, to begin on October 1, 2019. BJA may, in certain cases, provide
additional funding in future years to awards made under this solicitation, through continuation awards. In making
decisions regarding continuation awards, OJP will consider, among other factors, the availability of appropriations, when
the program or project was last competed, OJP’s strategic priorities, and OJP’s assessment of both the management of the
award (for example, timeliness and quality of progress reports), and the progress of the work funded under the award.
Contact Information:
Response Center
800-518-4726
80. Adult Drug Court Discretionary Grant Program (BJA)
https://www.bja.gov/Funding/ADC19.pdf
FOA Number: BJA-2019-15084 Application due: April 16, 2019
Description: The ADC Discretionary Grant Program provides financial and technical assistance to states, state courts,
local courts, units of local government, and federally recognized Indian tribal governments to develop and implement
drug courts and veterans treatment courts. BJA is accepting applications for FY 2019 grants to either establish new drug
courts or enhance existing drug court programs using evidence-based principles and practices. BJA also supports courts
that integrate the National Association of Drug Court Professionals (NADCP) Adult Drug Court Best Practice Standards
(drug court standards) into existing drug court services
Eligibility: For Category 1: Implementation and Category 2: Enhancement, eligible applicants are states, territories, state
and local courts, counties, units of local government, and federally recognized Indian tribal governments (as determined
by the Secretary of the Interior) on behalf of a single jurisdiction drug court.
For Category 3: Statewide, eligible applicants are state agencies such as the State Administering Agency (SAA), the
Administrative Office of the Courts, and the State Substance Abuse Agency. State agencies can also include state criminal
justice agencies and other state agencies involved with the provision of substance abuse and/or mental illness services, or
related services, to criminal substance abusers.
Award Information: BJA expects to make up to 85 awards. For category 1: $500,000 each for up to 4 years, for
Category 2: $500,000 each for up to 3 years, and for Category 3: per applicant for Subcategories A and B: $2,000,000 for
state-based coordination of services at a maximum of $500,000 per applicant under subcategory A for 3 years and a
maximum of $1,500,000 is available per applicant under subcategory B for 4 years.
Contact Information:
Response Center
800-518-4726
73
81. Adult Drug Court and Veterans Treatment Court Planning, Training, Technical
Assistance and Resource Center Initiative (BJA)
https://www.bja.gov/funding/ADCVTCTTA19.pdf
FOA Number: BJA-2019-15086 Application due: April 16, 2019
Description: This solicitation seeks providers to support both Adult Drug Court (ADC) and Veterans Treatment Court
(VTC) Program grantees. ADC TTA providers for all categories in this solicitation are expected to participate in an ADC
TTA collaborative to work together to assist states, veterans, tribes, and local justice system officials and treatment
professionals to implement evidence-based drug court practices.
1) Adult Drug Court Planning Initiative
2) Adult Drug Court Training Initiative and the National Drug Court Resource Policy, and Evidence-based
practice center
3) Adult Drug Court Site-specific technical assistance program
4) Adult Drug Court State-based technical assistance program
5) Veterans Treatment Court Site-specific Training and Technical Assistance
6) Tribal Healing to Wellness Drug Court Site-specific Training and Technical Assistance
Eligibility: Eligible applicants are limited to for-profit (commercial) organizations, nonprofit organizations (including
tribal organizations), faith-based and community organizations, and institutions of higher education (including tribal
institutions of higher education) with demonstrated expertise in assisting communities to develop, implement, and
enhance drug courts.
The applicant must be the entity that would have primary responsibility for carrying out the award, including
administering the funding and managing the entire project. An entity may also be proposed as a subrecipient (subgrantee)
in more than one application.
Award Information: BJA expects to make up to 7 awards of up to $20,700,000.
Contact Information:
Response Center
800-518-4726
82. U.S. Department of Justice Coordinated Tribal Assistance Solicitation
https://www.justice.gov/tribal/page/file/1114606/download
Application due: March 12, 2019
Description: To provide comprehensive training and technical assistance to tribes in the areas of alcohol and substance
abuse related crime, tribal courts and tribal justice systems, Alaska Native justice systems, addressing violent crime and
supporting prosecutors in tribal communities.
Eligibility: Non-Government Organizations. Eligible App Subcategories: For-Profit, Non-Profit. Only federally
recognized Indian tribes, as determined by the Secretary of the Interior may apply
74
Award Information: BJA expects to issue 5 awards of $150,000 totaling $750,000 over 3 years for Comprehensive tribal
justice systems strategic planning. For Tribal Justice Systems, $250,000 to 750,000 per award totaling $16.8 million total
over 3 years. For Tribal Justice Systems infrastructure program $1-4 million per award over three years totaling $7.5
million.
Contact Information:
Technical Application Assistance
Top Related